[go: up one dir, main page]

CN100584459C - Application of Dehydroabietine Aminothiourea Catalyst in High Enantiomeric Two-handed Synthesis of Chiral Compounds - Google Patents

Application of Dehydroabietine Aminothiourea Catalyst in High Enantiomeric Two-handed Synthesis of Chiral Compounds Download PDF

Info

Publication number
CN100584459C
CN100584459C CN200810150140A CN200810150140A CN100584459C CN 100584459 C CN100584459 C CN 100584459C CN 200810150140 A CN200810150140 A CN 200810150140A CN 200810150140 A CN200810150140 A CN 200810150140A CN 100584459 C CN100584459 C CN 100584459C
Authority
CN
China
Prior art keywords
nitro
butanone
ketone
phenyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200810150140A
Other languages
Chinese (zh)
Other versions
CN101318146A (en
Inventor
王锐
蒋先兴
张义福
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lanzhou University
Original Assignee
Lanzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lanzhou University filed Critical Lanzhou University
Priority to CN200810150140A priority Critical patent/CN100584459C/en
Publication of CN101318146A publication Critical patent/CN101318146A/en
Application granted granted Critical
Publication of CN100584459C publication Critical patent/CN100584459C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开了一类脱氢松香胺-手性硫脲催化剂在高对映体双手控合成γ-硝基-芳香酮类和γ-硝基-芳香杂酮类手性化合物中的应用。本发明成功地利用自然界的手性源合成了具有高催化活性的一类新的脱氢松香胺-手性硫脲催化剂。该类催化剂价格低廉,容易修饰和制备,处理简单,容易从产物中分离和回收,可再生利用,拓展了有限的已知硫脲催化剂的范围。本发明实现了同一种催化剂在相同的反应体系中,高效率高活性的不对称催化生成不同构型的高光学纯目标产物。本方法操作简单,不使用金属试剂,环境污染少;反应条件温和,不必在苛刻的无水、无氧条件下进行,可以在空气中进行反应。The invention discloses the application of a dehydroabietic amine-chiral thiourea catalyst in the dual-handed synthesis of gamma-nitro-aromatic ketones and gamma-nitro-aromatic heteroketone chiral compounds with high enantiomers. The invention successfully utilizes natural chiral sources to synthesize a new class of dehydroabietic amine-chiral thiourea catalysts with high catalytic activity. This type of catalyst is cheap, easy to modify and prepare, simple to handle, easy to separate and recover from the product, recyclable, and expands the range of limited known thiourea catalysts. The invention realizes the high-efficiency and high-activity asymmetric catalysis of the same catalyst in the same reaction system to generate high optically pure target products with different configurations. The method is simple to operate, does not use metal reagents, and has less environmental pollution; the reaction condition is mild, and it does not need to be carried out under harsh anhydrous and oxygen-free conditions, and the reaction can be carried out in the air.

Description

脱氢松香胺硫脲催化剂在高对映体双手控合成手性化合物中的应用 Application of Dehydroabietine Aminothiourea Catalyst in High Enantiomeric Two-handed Synthesis of Chiral Compounds

技术领域 technical field

本发明涉及一类脱氢松香胺-手性硫脲催化剂在高对映体双手控合成γ-硝基-芳香酮类和γ-硝基-芳香杂酮类手性化合物中的应用。The invention relates to the application of a class of dehydroabietic amine-chiral thiourea catalysts in the dual-handed synthesis of gamma-nitro-aromatic ketones and gamma-nitro-aromatic heteroketone chiral compounds with high enantiomers.

背景技术 Background technique

不对称有机催化作为二十一世纪新出现的概念,因其高效性和高选择性,成为构建分子骨架的重要工具,在有机合成及制药工业中发挥着巨大作用,为医药、化学、材料和生物学的发展提供了广阔的应用前景。不对称Michael加成产物:γ-硝基羰基化合物在有机合成中是一类非常有用的合成中间体。例如:γ-硝基-芳香酮类和γ-硝基-芳香杂酮类手性化合物可以进一步转化为在药物化学上非常有用的手性吡咯烷衍生物等(R.Galeazzi,G.Martelli,G.Mobbili,M.Orena,S.Rinaldi,Tetrahedron:Asymmetry 2003,14,3353.),而不同构型的手性化合物其药物活性是不同的。因此,如果能实现不同构型控制γ-硝基-芳香酮类和γ-硝基-芳香杂酮类手性化合物的合成,那么将极大的推动医药合成的发展。As a new concept in the 21st century, asymmetric organocatalysis has become an important tool for building molecular skeletons due to its high efficiency and high selectivity. It plays a huge role in organic synthesis and the pharmaceutical industry. The development of biology provides broad application prospects. Asymmetric Michael addition products: γ-nitrocarbonyl compounds are a class of very useful synthetic intermediates in organic synthesis. For example: gamma-nitro-aromatic ketones and gamma-nitro-aromatic heteroketone chiral compounds can be further converted into very useful chiral pyrrolidine derivatives etc. (R.Galeazzi, G.Martelli, G.Mobbili, M.Orena, S.Rinaldi, Tetrahedron: Asymmetry 2003, 14, 3353.), and the chiral compounds of different configurations have different pharmaceutical activities. Therefore, if the synthesis of chiral compounds of γ-nitro-aromatic ketones and γ-nitro-aromatic heteroketones with different configurations can be realized, it will greatly promote the development of pharmaceutical synthesis.

Takemoto等(T.Okino,Y.Hoashi,Y.Takemoto,J.Am.Chem.Soc.2003,125,12672..)首次报道了用手性双功能硫脲催化剂催化的Michael加成反应,他们用硫脲催化剂有效地催化了丙二酸二乙酯对一系列芳基取代的硝基乙烯的加成反应,该反应得到了较好的收率,但只能得到(S)构型的加成产物。Takemoto et al. (T.Okino, Y.Hoashi, Y.Takemoto, J.Am.Chem.Soc.2003, 125, 12672..) reported for the first time the Michael addition reaction catalyzed by a chiral bifunctional thiourea catalyst, they The addition of diethyl malonate to a series of aryl-substituted nitroethenes was efficiently catalyzed by thiourea catalysts in good yields but only in the (S) configuration. into a product.

目前为止,多个研究小组合成并报道了个自的双功能硫脲催化剂并应用于硝基烯烃的Michael加成反应之中。例如:Wang等(J.Wang,H.Li,W.H.Duan,L.S.Zu,W.Wang,Org.Lett.2005,7,4713.)报道了一种手性联萘硫脲催化剂1a;Soós小组(B.Vakulya,S.Varga,A.Csampai,T.Soos,Org.Lett.2005,7,1967.),Connon小组(S.H.McCooey,S.J.Connon,Angew.Chem.Int.Ed.2005,44,6367.)和Dixon小组(P.S.Hynes,D.Stranges,P.A.Stupple,A.Guarna,D.J.Dixon,Org.Lett.2007,9,2107.)对天然金鸡纳生物碱结构进行修饰,用硫脲取代C-9上的羟基,设计出了新型的由金鸡纳碱衍生的双功能硫脲催化剂2a-2b;Jacobsen研究小组(M.P.Lalonde,Y.G.Chen,E.N.Jacobsen,Angew.Chem.Int.Ed.2006,45,6366.)报道了一级胺硫脲双功能催化剂3a;Tsogoeva(D.A.Yalalov,S.B.Tsogoeva,S.Schmatz,Adv.Synth.Catal.2006,348,826.)报道了双功能手性一级胺硫脲催化剂4a-4b;Tang等(C-L.Cao,M-C.Ye,X-L.Sun,Y.Tang,Org.Lett.2006,8,2901.)报道了脯氨酸衍生的硫脲双功能手性催化剂5a;此外在最近,Ma等研究小组(K.Liu,H-F.Cui,J.Nie,K-Y.Dong,X-J.Li,J-A.Ma,Org.Lett.2007,9,923.),报道了以糖环衍生的硫脲双功能有机催化剂6a-6b。硫脲催化剂1a,2a-2b,3a,4a-4b,5a和6a-6b的化学结构式如图1所示。尽管以上研究小组合成了多种硫脲催化剂并成功的应用于不对称手性合成之中,但是相比其他类型的催化剂,目前已经报道的硫脲催化剂还很少,其设计合成仍然是一项相当大的挑战。目前,新型高效硫脲催化剂的设计合成仍然是有机化学家努力的目标。而且值得注意的是,上述报道的手性胺-硫脲催化剂只能在有效地控制反应产物其中之一构型上表现出高的催化活性,而当该类型的手性胺-硫脲催化剂在控制反应产物另一构型的反应中却表现出很差的反应性。例如:Ma等报道的以糖环衍生的硫脲双功能有机催化剂6a-6b,该硫脲催化剂中的环己二胺部分构型为(1R,2R)时,有效的催化了苯乙酮对硝基烯烃的不对称Michael加成反应,其加成产物为(S)-γ-硝基酮。但是,当催化剂中的环己二胺部分构型为(1S,2S)时,表现出了差的反应性,生成的加成产物(R)-γ-硝基苯乙酮仅仅有46%的产率,而对映体选择性也有明显的所下降(见图2),也就是说该催化剂中糖环部分对环己二胺部分在发挥其催化活性上具有很高的选择性。该研究表明只有其环己二胺部分构型为(1R,2R)时,该硫脲催化剂才能表现出催化高效性,得到好的产率和在立体空间上很好的控制构型(Si-面手控),得到高度光学纯度的(S)-γ-硝基酮。但是,硫脲催化剂中糖环部分表现了对(1S,2S)-环己二胺很差的适配性,导致在Re-面手性控制加成反应时,得到的加成产物(R)-γ-硝基苯乙酮不仅显示了差的产率,而且还显示了相对低的对映体选择性。更重要的是,迄今为止还没有报道过高对映体合成γ-硝基-芳香杂酮类手性化合物的相关合成方法。So far, several research groups have synthesized and reported their own bifunctional thiourea catalysts and applied them in the Michael addition reaction of nitroalkenes. For example: Wang et al. (J.Wang, H.Li, W.H.Duan, L.S.Zu, W.Wang, Org.Lett.2005, 7, 4713.) reported a chiral binaphthylthiourea catalyst 1a; Soós group ( B.Vakulya, S.Varga, A.Csampai, T.Soos, Org.Lett.2005, 7, 1967.), Connon group (S.H.McCooey, S.J.Connon, Angew.Chem.Int.Ed.2005, 44, 6367 .) and Dixon group (P.S.Hynes, D.Stranges, P.A.Stupple, A.Guarna, D.J.Dixon, Org.Lett.2007,9,2107.) modify the structure of natural cinchona alkaloids, replace C- with thiourea The hydroxyl group on 9 has designed a novel bifunctional thiourea catalyst 2a-2b derived from cinchona base; 6366.) reported the bifunctional catalyst 3a of a primary aminothiourea; Urea Catalysts 4a-4b; Tang et al. (C-L.Cao, M-C.Ye, X-L.Sun, Y.Tang, Org.Lett.2006, 8, 2901.) reported proline-derived thiourea bifunctional chiral catalysts 5a; In addition, recently, Ma et al. (K.Liu, H-F.Cui, J.Nie, K-Y.Dong, X-J.Li, J-A.Ma, Org.Lett.2007, 9, 923.), reported the Sugar ring-derived thiourea bifunctional organocatalysts 6a–6b. The chemical structural formulas of thiourea catalysts 1a, 2a-2b, 3a, 4a-4b, 5a and 6a-6b are shown in FIG. 1 . Although the above research groups have synthesized a variety of thiourea catalysts and successfully applied them in asymmetric chiral synthesis, compared with other types of catalysts, there are very few thiourea catalysts reported so far, and their design and synthesis is still a challenge. Quite a challenge. At present, the design and synthesis of new high-efficiency thiourea catalysts is still the goal of organic chemists. And it is worth noting that the chiral amine-thiourea catalyst reported above can only show high catalytic activity in effectively controlling one of the configurations of the reaction products, and when this type of chiral amine-thiourea catalyst is in The reactions that control the other configuration of the reaction product show poor reactivity. For example: the thiourea bifunctional organic catalysts 6a-6b derived from sugar rings reported by Ma et al., when the configuration of the cyclohexanediamine moiety in the thiourea catalyst is (1R, 2R), it effectively catalyzes the reaction of acetophenone on Asymmetric Michael addition of nitroalkenes, and the addition product is (S)-γ-nitroketone. However, when the configuration of cyclohexanediamine in the catalyst is (1S, 2S), poor reactivity is shown, and the adduct (R)-γ-nitroacetophenone generated has only 46% Yield, and enantioselectivity also has obvious decline (see Figure 2), that is to say that the sugar ring part in this catalyst has very high selectivity to the cyclohexanediamine part in exerting its catalytic activity. This study shows that only when the configuration of the cyclohexanediamine moiety is (1R, 2R), the thiourea catalyst can show high catalytic efficiency, obtain good yield and well-controlled configuration in the stereo space (Si- surface manual control) to obtain (S)-γ-nitroketone with high optical purity. However, the sugar ring moiety in the thiourea catalyst showed poor compatibility to (1S,2S)-cyclohexanediamine, resulting in the addition product (R) -γ-Nitroacetophenone not only showed poor yield, but also relatively low enantioselectivity. More importantly, no related synthetic methods for the synthesis of γ-nitro-aromatic heteroketone chiral compounds with high enantiomers have been reported so far.

发明内容 Contents of the invention

鉴于目前的硫脲催化剂在相同的反应催化体系中只能有效地催化合成一种构型的反应产物,本发明的目的旨在提供一类能在相同的反应催化体系中有效地催化合成两种构型((S)构型或(R)构型)反应产物的脱氢松香胺-手性硫脲催化剂。In view of the current thiourea catalysts can only effectively catalyze the synthesis of a reaction product of a configuration in the same reaction catalysis system, the purpose of the present invention is to provide a class that can effectively catalyze the synthesis of two configurations in the same reaction catalysis system Configuration ((S) configuration or (R) configuration) reaction product of dehydroabietamine-chiral thiourea catalyst.

本发明的另一目的在于提供一种高对映体双手控合成γ-硝基-芳香酮类及γ-硝基-芳香杂酮类手性化合物及其制备方法。Another object of the present invention is to provide a hand-controlled synthesis of γ-nitro-aromatic ketones and γ-nitro-aromatic heteroketone chiral compounds with high enantiomers and a preparation method thereof.

本发明还有一个目的是将脱氢松香胺-手性硫脲催化剂在高对映体双手控合成γ-硝基-芳香酮类及γ-硝基-芳香杂酮类手性化合物中的应用。Another object of the present invention is the application of dehydroabietic amine-chiral thiourea catalyst in the hand-controlled synthesis of gamma-nitro-aromatic ketones and gamma-nitro-aromatic heteroketone chiral compounds with high enantiomers .

(1).一类脱氢松香胺-手性硫脲催化剂,其结构式如(I)所示:(1). A class of dehydroabietic amine-chiral thiourea catalyst, its structural formula is as shown in (I):

Figure C20081015014000071
Figure C20081015014000071

(I)式中n为1,或为0;R基团为(1S,2S)-环己二胺,或为(1S,2R)-环己二胺,或为3,5-二三氟甲基苯胺。(I) n is 1 in the formula, or is 0; R group is (1S, 2S)-cyclohexanediamine, or is (1S, 2R)-cyclohexanediamine, or is 3,5-ditrifluoro methylaniline.

一类脱氢松香胺-手性硫脲催化剂的制备方法:A kind of preparation method of dehydroabietamine-chiral thiourea catalyst:

将脱氢松香胺或降解脱氢松香胺溶于无水乙醚溶液中,加入脱氢松香胺或降解脱氢松香胺1倍量的二环己基碳二亚胺(DCC),搅拌15分钟后,在0℃条件下滴加入脱氢松香胺或降解脱氢松香胺5倍量的二硫化碳,反应8小时,过滤,柱层析(H60硅胶,正己烷∶乙酸乙酯=5∶1)后得到异硫氰酸酯;然后将(1S,2S)-环己二胺,或(1R,2R)-环己二胺,或3,5-二三氟甲基苯胺溶于无水二氯甲烷中,在0℃条件下滴加入异硫氰酸酯,在室温下反应12小时,柱层析(H60硅胶,乙酸乙酯∶甲醇=6∶1)后得到终产物。Dissolve dehydroabietamine or degraded dehydroabietamine in anhydrous ether solution, add dehydroabietamine or dehydroabietamine 1 times the amount of dicyclohexylcarbodiimide (DCC), after stirring for 15 minutes, Add dehydroabietamine or dehydroabietamine 5 times the amount of carbon disulfide dropwise at 0°C, react for 8 hours, filter, and column chromatography (H60 silica gel, n-hexane:ethyl acetate=5:1) to obtain the iso Thiocyanate; then (1S, 2S)-cyclohexanediamine, or (1R, 2R)-cyclohexanediamine, or 3,5-bistrifluoromethylaniline were dissolved in anhydrous dichloromethane, Isothiocyanate was added dropwise at 0°C, reacted at room temperature for 12 hours, and the final product was obtained after column chromatography (H60 silica gel, ethyl acetate:methanol=6:1).

上述反应用化学式表示如下:Above-mentioned reaction is expressed as follows with chemical formula:

(2).γ-硝基-芳香酮类手性化合物,其结构式如(II)所示:(2). Gamma-nitro-aromatic ketone chiral compounds, the structural formula of which is shown in (II):

(S)-构型γ-硝基-芳香酮    (R)-构型γ-硝基-芳香酮(S)-configuration γ-nitro-aromatic ketone (R)-configuration γ-nitro-aromatic ketone

                      (II)(II)

(II)式中R1为-H,或为-Me,或为-OMe,或为-Cl,或为-Br,或为-F。(II) In the formula, R 1 is -H, or -Me, or -OMe, or -Cl, or -Br, or -F.

R2为-Ph,或为-napathyl,或为-Cl-Ph,或为-Br-Ph,或为-F-Ph,或为-thiophenyl,或为-furanyl,或为-Me-Ph,或为-OMe-Ph。 R is -Ph, or -napathyl, or -Cl-Ph, or -Br-Ph, or -F-Ph, or -thiophenyl, or -furanyl, or -Me-Ph, or for -OMe-Ph.

高对映体双手控合成γ-硝基-芳香酮类手性化合物的制备方法:The preparation method of high enantiomeric hands-on synthesis of gamma-nitro-aryl ketone chiral compounds:

将底物硝基烯烃化合物和用量为底物硝基烯烃化合物15mol%的脱氢松香胺-手性硫脲催化剂,用量为底物硝基烯烃化合物15mol%苯甲酸溶于二氯甲烷中,在0℃条件下加入用量为底物硝基烯烃化合物3倍量芳香酮化合物,反应2小时后,在室温下继续反应60小时。反应完全后,柱层析(H60硅胶,石油醚∶乙酸乙酯=8∶1)得到终产物。上述反应用化学式表示如下:Substrate nitroalkene compound and consumption are the dehydroabietic amine-chiral thiourea catalyst of substrate nitroalkene compound 15mol%, and consumption is that substrate nitroalkene compound 15mol% benzoic acid is dissolved in methylene chloride, in Add the aromatic ketone compound in an amount 3 times that of the substrate nitroalkene compound at 0°C, react for 2 hours, and continue the reaction at room temperature for 60 hours. After the reaction was complete, the final product was obtained by column chromatography (H60 silica gel, petroleum ether: ethyl acetate = 8:1). Above-mentioned reaction is expressed as follows with chemical formula:

(3).γ-硝基-芳香杂酮类手性化合物,其结构式如(III)所示:(3). Gamma-nitro-aromatic heteroketone chiral compounds, the structural formula of which is shown in (III):

Figure C20081015014000082
Figure C20081015014000082

(S)-构型γ-硝基-芳香杂酮(S)-configuration γ-nitro-aromatic heteroketone

Figure C20081015014000083
Figure C20081015014000083

(R)-构型γ-硝基-芳香杂酮(R)-configuration γ-nitro-aromatic heteroketone

(III)(III)

(III)式中X为O,或为S;Y为-CH(-C),或为N。(III) In the formula, X is O, or is S; Y is -CH(-C), or is N.

R3为-Ph,或为-napathyl,或为-Cl-Ph,或为-Br-Ph,或为-F-Ph,或为-thiophenyl,或为-furanyl,或为-Me-Ph,或为-OMe-Ph。R 3 is -Ph, or -napathyl, or -Cl-Ph, or -Br-Ph, or -F-Ph, or -thiophenyl, or -furanyl, or -Me-Ph, or for -OMe-Ph.

R4为-H,或为-Me,或为-Cl,或为-Br,或为-F。R 4 is -H, or -Me, or -Cl, or -Br, or -F.

R5为-H,或为-Me,或为-Cl,或为-Br,或为-F。R 5 is -H, or -Me, or -Cl, or -Br, or -F.

R6为-H,或为-Me,或为-Cl,或为-Br,或为-F。R 6 is -H, or -Me, or -Cl, or -Br, or -F.

R7为-H,或为-Me,或为-Cl,或为-Br,或为-F。R 7 is -H, or -Me, or -Cl, or -Br, or -F.

R8为-H,或为-Me。R 8 is -H, or -Me.

高对映体双手控合成γ-硝基-芳香杂酮类手性化合物的制备方法:The preparation method of high-enantiomeric double-handedly synthesized γ-nitro-aromatic heteroketone chiral compounds:

将底物硝基烯烃化合物和用量为底物硝基烯烃化合物15mol%的脱氢松香胺-手性硫脲催化剂,用量为底物硝基烯烃化合物15mol%苯甲酸溶于二氯甲烷中,在0℃条件下加入用量为底物硝基烯烃化合物3倍量芳香杂酮化合物,反应2小时后,在室温下继续反应72小时。反应完全后,柱层析(H60硅胶,石油醚∶乙酸乙酯=8∶1)得到终产物。上述反应用化学式表示如下:Substrate nitroalkene compound and consumption are the dehydroabietic amine-chiral thiourea catalyst of substrate nitroalkene compound 15mol%, and consumption is that substrate nitroalkene compound 15mol% benzoic acid is dissolved in methylene chloride, in At 0°C, an aromatic heteroketone compound was added in an amount three times that of the substrate nitroalkene compound. After reacting for 2 hours, the reaction was continued at room temperature for 72 hours. After the reaction was complete, the final product was obtained by column chromatography (H60 silica gel, petroleum ether: ethyl acetate = 8:1). Above-mentioned reaction is expressed as follows with chemical formula:

Figure C20081015014000091
Figure C20081015014000091

在本发明中,我们通过对双功能硫脲催化剂的性质和结构研究,利用易得的天然有机产物脱氢松香胺设计并合成了一类新的脱氢松香胺-硫脲催化剂,用脱氢松香胺-硫脲催化剂高对映体双手控催化合成了γ-硝基-芳香酮类和γ-硝基-芳香杂酮类手性化合物。本发明优点体现在以下几点:In the present invention, we have designed and synthesized a new class of dehydroabietamine-thiourea catalysts by utilizing the easily available natural organic product dehydroabietamine-thiourea catalysts by studying the properties and structures of bifunctional thiourea catalysts. γ-nitro-aromatic ketones and γ-nitro-aromatic heteroketone chiral compounds were synthesized by high-enantiomer double-handed catalysis of rosin amine-thiourea catalyst. The advantages of the present invention are reflected in the following points:

(1).我们成功的利用自然界的手性源合成了具有高催化活性的一类新的脱氢松香胺-手性硫脲催化剂。该类催化剂价格低廉,容易修饰和制备,处理简单,容易从产物中分离和回收,可再生利用。不仅拓展了有限的已知硫脲催化剂的范围,而且显示了脱氢松香胺类天然产物在不对称催化领域应用的巨大潜力。(1). We successfully synthesized a new class of dehydroabietic amine-chiral thiourea catalysts with high catalytic activity using natural chiral sources. This type of catalyst is cheap, easy to modify and prepare, simple to handle, easy to separate and recover from products, and can be recycled. It not only expands the range of limited known thiourea catalysts, but also shows the great potential of dehydroabietic amine natural products in the field of asymmetric catalysis.

(2).在目前不对称合成领域,极少有同一种催化剂在相同的反应体系下,高效率高活性地不对称催化生成(S)和(R)两种构型的高对映体产物,在背景材料中的硫脲催化剂(1a,2a-2b,3a,4a-4b,5a和6a-6b)也不能够实现上述合成高对映体产物的目的。研究表明,本发明的脱氢松香胺-手性硫脲催化剂能够在相同的反应体系下,高效率高活性地催化生成S)和(R)两种构型的高对映体产物。其硫脲催化剂中,脱氢松香胺部分对环己二胺部分在发挥其催化活性上具有很低的选择性。也就是说,环己二胺部分构型为(1R,2R)或(1S,2S)时,该类型催化剂均能发挥其优秀的催化活性,而不会损失产物的高产率和高光学纯度。在研究中,当脱氢松香胺-手性硫脲催化剂中环己二胺部分构型为(1R,2R)时,不对称催化合成的γ-硝基-芳香酮类及γ-硝基-芳香杂酮类手性化合物均能够达到99%的产率和大于99%对映体选择性;当环己二胺部分构型为(1S,2S)时,不对称催化合成的γ-硝基-芳香酮类及γ-硝基-芳香杂酮类手性化合物也同样能够达到99%的产率和大于99%对映体选择性。硫脲催化剂中环己二胺部分构型的不同,不仅不会降低催化剂的活性、降低目标产物的产率,而且在不同的空间手性控制上催化了不同构型产物的生成。简言之,该脱氢松香胺-手性硫脲催化剂能够在发挥高效率高催化活性的情况下,高对映体双手性控制产物的生成。本发明的脱氢松香胺-手性硫脲催化剂实现了有机合成领域同一种催化剂在相同的反应体系中,高效率高活性的不对称催化生成不同构型的高光学纯目标产物。(2). In the current field of asymmetric synthesis, there are very few same catalysts that can asymmetrically catalyze high-efficiency and high-activity high-enantiomeric products in two configurations (S) and (R) under the same reaction system. , the thiourea catalysts (1a, 2a-2b, 3a, 4a-4b, 5a and 6a-6b) in the background material also cannot achieve the above-mentioned purpose of synthesizing high enantiomeric products. Studies have shown that the dehydroabietic amine-chiral thiourea catalyst of the present invention can catalyze high-enantiomer products of S) and (R) configurations with high efficiency and high activity under the same reaction system. In its thiourea catalyst, the dehydroabietic amine moiety has very low selectivity to the cyclohexanediamine moiety in exerting its catalytic activity. That is to say, when the partial configuration of cyclohexanediamine is (1R, 2R) or (1S, 2S), this type of catalyst can exert its excellent catalytic activity without losing the high yield and high optical purity of the product. In the research, when the configuration of cyclohexanediamine in the dehydroabietic amine-chiral thiourea catalyst is (1R, 2R), the γ-nitro-aromatic ketones and γ-nitro-aromatic ketones synthesized by asymmetric catalysis Heteroketone chiral compounds can achieve 99% yield and greater than 99% enantioselectivity; when the configuration of cyclohexanediamine is (1S, 2S), the asymmetrically catalyzed γ-nitro- Aromatic ketones and γ-nitro-aromatic heteroketone chiral compounds can also achieve 99% yield and greater than 99% enantioselectivity. The different configurations of the cyclohexanediamine moiety in the thiourea catalyst not only do not reduce the activity of the catalyst and the yield of the target product, but also catalyze the formation of products with different configurations in different spatial chiral controls. In short, the dehydroabietic amine-chiral thiourea catalyst can control the formation of products with high enantiomeric chirality under the condition of high efficiency and high catalytic activity. The dehydroabietic amine-chiral thiourea catalyst of the present invention realizes the high-efficiency and high-activity asymmetric catalysis of the same catalyst in the same reaction system in the field of organic synthesis to generate high optically pure target products with different configurations.

(3).本发明中,我们提供了一种高对映体双手控合成γ-硝基-芳香酮类及γ-硝基-芳香杂酮类手性化合物有效的制备方法。本方法操作简单,不使用金属试剂,环境污染少,对环境友好;反应条件温和,不必在苛刻的无水、无氧条件下进行,可以在空气中进行反应。(3). In the present invention, we provide an effective preparation method for high enantiomeric hands-on synthesis of γ-nitro-aromatic ketones and γ-nitro-aromatic heteroketone chiral compounds. The method is simple to operate, does not use metal reagents, has less environmental pollution, and is environmentally friendly; the reaction condition is mild, and the reaction can be carried out in the air instead of harsh anhydrous and oxygen-free conditions.

具体实施方式 Detailed ways

本发明将通过下面的实施例加以说明,但是不受此限。The invention will be illustrated by the following examples, but not limited thereto.

本发明的产物用质谱、核磁、红外鉴定,高效液相(HPLC)测定对映体选择性。The product of the present invention is identified by mass spectrometry, NMR and infrared, and the enantioselectivity is determined by high performance liquid phase (HPLC).

实施例1:脱氢松香胺-硫脲催化剂(简称:(1R,2R)-CHDA-DHATU),[英文全称1-((1R,2R)-2-aminocyclohexyl)-3-(((1R,4aS,10aR)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl)methyl)thiourea]结构式如下:Embodiment 1: dehydroabietamine-thiourea catalyst (abbreviation: (1R, 2R)-CHDA-DHATU), [English full name 1-((1R, 2R)-2-aminocyclohexyl)-3-(((1R, 4aS, 10aR)-7-isopropyl-1, 4a-dimethyl-1, 2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl)methyl)thiourea] structural formula is as follows:

Figure C20081015014000111
Figure C20081015014000111

脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备方法:Dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU preparation method:

将2.85g(10mmol)脱氢松香胺溶于50ml无水乙醚溶液中,加入2.06g(10mmol)二环己基碳二亚胺(DCC)。搅拌15分钟后,在0℃条件下滴加入4ml(50mmol)二硫化碳,反应在室温下进行8小时。过滤,将滤液浓缩后,柱层析(H60硅胶,正己烷∶乙酸乙酯=5∶1)得到异硫氰酸酯3.1g(95%产率)。Dissolve 2.85g (10mmol) of dehydroabietamine in 50ml of anhydrous ether solution, and add 2.06g (10mmol) of dicyclohexylcarbodiimide (DCC). After stirring for 15 minutes, 4 ml (50 mmol) of carbon disulfide was added dropwise at 0° C., and the reaction was carried out at room temperature for 8 hours. After filtration and concentration of the filtrate, column chromatography (H60 silica gel, n-hexane:ethyl acetate=5:1) gave 3.1 g of isothiocyanate (95% yield).

将1.14g(10mmol)(1R,2R)-环己二胺溶于40ml无水二氯甲烷中,在0℃条件下,将溶有3.1g异硫氰酸酯的20ml无水二氯甲烷混合溶液滴加入(1R,2R)-环己二胺和无水二氯甲烷混合溶液中,历时1.5小时。加完后,上述反应在室温下继续反应12小时。浓缩、柱层析(H60硅胶,乙酸乙酯∶甲醇=6∶1)得到白色固体终产物3.3g(产率为80%)。Dissolve 1.14g (10mmol) (1R, 2R)-cyclohexanediamine in 40ml of anhydrous dichloromethane, and mix 3.1g of isothiocyanate dissolved in 20ml of anhydrous dichloromethane at 0°C The solution was added dropwise into a mixed solution of (1R,2R)-cyclohexanediamine and anhydrous dichloromethane over a period of 1.5 hours. After the addition was complete, the above reaction was continued at room temperature for 12 hours. Concentration and column chromatography (H60 silica gel, ethyl acetate:methanol=6:1) gave 3.3 g of the final product as a white solid (80% yield).

[α]20 D=+69(c=1.0,CHCl3);熔点:88-89℃。[α] 20 D = +69 (c = 1.0, CHCl 3 ); melting point: 88-89°C.

核磁分析:NMR analysis:

1H NMR(300MHz,[D6]DMSO):δ7.38(br,1H),7.12-7.15(d,J=8.1Hz,1H),6.92-6.94(d,J=8.1Hz,1H),6.83(s,1H),3.74(br,1H),3.38-3.42(m,2H),2.68-2.79(m,3H),2.39-2.48(m,1H),2.23-2.27(d,J=12.9Hz,1H),1.97-2.00(m,1H),1.49-1.81(m,7H),1.34-1.38(m,2H),1.24-1.28(m,2H),1.07-1.19(m,9H),0.91-1.04(m,7H);13C NMR(75MHz,[D6]DMSO):δ147.0,144.9,134.5,126.4,124.1,123.5,54.2,44.5,37.9,37.3,36.99,35.8,34.2,32.9,31.5,29.6,25.1,24.5,24.3,23.9,18.7,18.5,18.2. 1 H NMR (300MHz, [D 6 ]DMSO): δ7.38 (br, 1H), 7.12-7.15 (d, J=8.1Hz, 1H), 6.92-6.94 (d, J=8.1Hz, 1H), 6.83(s, 1H), 3.74(br, 1H), 3.38-3.42(m, 2H), 2.68-2.79(m, 3H), 2.39-2.48(m, 1H), 2.23-2.27(d, J=12.9 Hz, 1H), 1.97-2.00(m, 1H), 1.49-1.81(m, 7H), 1.34-1.38(m, 2H), 1.24-1.28(m, 2H), 1.07-1.19(m, 9H), 0.91-1.04 (m, 7H); 13 C NMR (75MHz, [D 6 ]DMSO): δ147.0, 144.9, 134.5, 126.4, 124.1, 123.5, 54.2, 44.5, 37.9, 37.3, 36.99, 35.8, 34.2, 32.9, 31.5, 29.6, 25.1, 24.5, 24.3, 23.9, 18.7, 18.5, 18.2.

红外光谱分析:3259,3066,2929,2860,2213,1549,1452,1378,1234,1202,1087,910,823,732,647cm-1.Infrared spectral analysis: 3259, 3066, 2929, 2860, 2213, 1549, 1452, 1378, 1234, 1202, 1087, 910, 823, 732, 647cm -1 .

高分辨质谱分析:High-resolution mass spectrometry analysis:

HRMS-ESI(m/z):calcd for C27H43N3S[M+H]+:442.3250;found:442.3245,1.1ppm.HRMS-ESI(m/z): calcd for C 27 H 43 N 3 S[M+H] + : 442.3250; found: 442.3245, 1.1ppm.

实施例2:脱氢松香胺-硫脲催化剂(简称:(1S,2S)-CHDA-DHATU),[英文全称:1-((1S,2S)-2-aminocyclohexyl)-3-(((1R,4aS,10aR)-7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl)methyl)thiourea]结构式如下:Embodiment 2: dehydroabietamine-thiourea catalyst (abbreviation: (1S, 2S)-CHDA-DHATU), [English full name: 1-((1S, 2S)-2-aminocyclohexyl)-3-(((1R , 4aS, 10aR)-7-isopropyl-1, 4a-dimethyl-1, 2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl)methyl)thiourea] structural formula is as follows:

Figure C20081015014000121
Figure C20081015014000121

脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU的制备方法与实施例1相同。The preparation method of dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU is the same as that of Example 1.

[α]20 D=-57(c=1.1,CHCl3);熔点:87-88℃。[α] 20 D = -57 (c = 1.1, CHCl 3 ); melting point: 87-88°C.

核磁分析:NMR analysis:

1H NMR(300MHz,[D6]DMSO):δ7.40(br,1H),7.14-7.16(d,J=8.1Hz,1H),6.93-6.96(dd,J=1.5Hz,8.1Hz,1H),6.84(s,1H),3.75(br,1H),3.35-3.44(m,2H),2.71-2.78(m,3H),2.40-2.46(m,1H),2.24-2.28(d,J=12.9Hz,1H),2.00(m,1H),1.47-1.87(m,7H),1.35-1.40(m,2H),1.21-1.25(m,2H),1.13-1.16(m,9H),0.95-0.96(m,7H);13C NMR(75MHz,[D6]DMSO):δ147.0,144.9,134.4,126.4,124.0,123.5,54.2,44.5,38.0,37.4,37.0,34.2,32.8,31.5,29.7,25.1,24.5,24.3,23.9,23.88,18.7,18.5,18.2. 1 H NMR (300MHz, [D 6 ]DMSO): δ7.40 (br, 1H), 7.14-7.16 (d, J=8.1Hz, 1H), 6.93-6.96 (dd, J=1.5Hz, 8.1Hz, 1H), 6.84(s, 1H), 3.75(br, 1H), 3.35-3.44(m, 2H), 2.71-2.78(m, 3H), 2.40-2.46(m, 1H), 2.24-2.28(d, J=12.9Hz, 1H), 2.00(m, 1H), 1.47-1.87(m, 7H), 1.35-1.40(m, 2H), 1.21-1.25(m, 2H), 1.13-1.16(m, 9H) , 0.95-0.96 (m, 7H); 13 C NMR (75MHz, [D 6 ]DMSO): δ147.0, 144.9, 134.4, 126.4, 124.0, 123.5, 54.2, 44.5, 38.0, 37.4, 37.0, 34.2, 32.8 , 31.5, 29.7, 25.1, 24.5, 24.3, 23.9, 23.88, 18.7, 18.5, 18.2.

红外光谱分析:3355,3114,3031,2919,2851,1953,1683,1549,1478,1380,1233,1062,947,875,754,698,628,543cm-1.Infrared spectral analysis: 3355, 3114, 3031, 2919, 2851, 1953, 1683, 1549, 1478, 1380, 1233, 1062, 947, 875, 754, 698, 628, 543cm -1 .

高分辨质谱分析:High-resolution mass spectrometry analysis:

HRMS-ESI(m/z):calcd for C27H43N3S[M+H]+:442.3250;found:442.3244,1.3ppm.HRMS-ESI(m/z): calcd for C 27 H 43 N 3 S[M+H] + : 442.3250; found: 442.3244, 1.3ppm.

实施例3:(S)-4-硝基-1,3-二苯基-1-丁酮和(R)-4-硝基-1,3-二苯基-1-丁酮结构式如下:Example 3: (S)-4-nitro-1,3-diphenyl-1-butanone and (R)-4-nitro-1,3-diphenyl-1-butanone have the following structural formulas:

Figure C20081015014000122
Figure C20081015014000122

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-4-硝基-1,3-二苯基-1-丁酮的方法:a. The method for preparing (S)-4-nitro-1,3-diphenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU:

将15mg(0.1mmol)底物硝基苯乙烯,6.6mg(0.015mmol)脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU,1.8mg(0.015mmol)苯甲酸溶于0.8ml二氯甲烷中,在0℃条件下,加入35μl(0.3mmol)苯乙酮,反应2小时后,在室温下继续反应60小时。反应完全后,用二氯甲烷萃取三次(每次8ml),用2g无水硫酸钠干躁。浓缩、柱层析(H60硅胶,石油醚∶乙酸乙酯=8∶1)得到白色固体终产物(S)-4-硝基-1,3-二苯基-1-丁酮26.6mg(99%产率)。Dissolve 15mg (0.1mmol) substrate nitrostyrene, 6.6mg (0.015mmol) dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, 1.8mg (0.015mmol) benzoic acid in 0.8ml di In methyl chloride, 35 μl (0.3 mmol) of acetophenone was added at 0° C., and after 2 hours of reaction, the reaction was continued at room temperature for 60 hours. After the reaction was complete, it was extracted three times with dichloromethane (8ml each time), and dried with 2g of anhydrous sodium sulfate. Concentration and column chromatography (H60 silica gel, petroleum ether: ethyl acetate = 8: 1) gave the final product (S)-4-nitro-1,3-diphenyl-1-butanone 26.6 mg (99 %Yield).

[α]20 D=-22(c=1.0,CHCl3);熔点:90-92℃。[α] 20 D = -22 (c = 1.0, CHCl 3 ); melting point: 90-92°C.

高效液相分析(HPLC):(手性柱Chiralcel AS-H,异丙醇/正己烷=15/85,0.9mL/min,紫外吸收254nm.)tmajor=18.41min,对映体选择性大于99%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AS-H, isopropanol/n-hexane=15/85, 0.9mL/min, UV absorption 254nm.) t major =18.41min, enantioselectivity greater than 99%.

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-4-硝基-1,3-二苯基-1-丁酮的方法:b. The method for preparing (R)-4-nitro-1,3-diphenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU:

将15mg(0.1mmol)底物硝基苯乙烯,6.6mg(0.015mmol)脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU,1.8mg(0.015mmol)苯甲酸溶于0.8ml二氯甲烷中,在0℃条件下加入35μl(0.3mmol)苯乙酮,反应2小时后,在室温下继续反应60小时。反应完全后,用二氯甲烷萃取三次(每次8ml),用2g无水硫酸钠干躁。浓缩、柱层析(H60硅胶,石油醚∶乙酸乙酯=8∶1)得到白色固体终产物(R)-4-硝基-1,3-二苯基-1-丁酮25.8mg(96%产率)。Dissolve 15mg (0.1mmol) substrate nitrostyrene, 6.6mg (0.015mmol) dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU, 1.8mg (0.015mmol) benzoic acid in 0.8ml di In methyl chloride, 35 μl (0.3 mmol) of acetophenone was added at 0° C., and after 2 hours of reaction, the reaction was continued at room temperature for 60 hours. After the reaction was complete, it was extracted three times with dichloromethane (8ml each time), and dried with 2g of anhydrous sodium sulfate. Concentration, column chromatography (H60 silica gel, petroleum ether: ethyl acetate = 8: 1) gave white solid final product (R)-4-nitro-1,3-diphenyl-1-butanone 25.8mg (96 %Yield).

[α]20 D=+12(c=1.3,CHCl3);熔点:91-92℃。[α] 20 D = +12 (c = 1.3, CHCl 3 ); melting point: 91-92°C.

高效液相分析(HPLC):(手性柱Chiralcel AS-H,异丙醇/正己烷=15/85,0.9mL/min,紫外吸收254nm.)tmajor=22.91min,tminor=17.94min,对映体选择性达到98%.。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AS-H, isopropanol/n-hexane = 15/85, 0.9mL/min, UV absorption 254nm.) t major = 22.91min, t minor = 17.94min, Enantioselectivity reaches 98%..

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.92-7.94(d,J=8Hz,2H),7.57-7.59(m,1H),7.45-7.48(m,2H),7.26-7.34(m,5H),4.82-4.87(dd,J=6.4Hz,12.4Hz,1H),4.67-4.72(dd,J=8.4Hz,12.8Hz,1H),4.24(m,1H),3.45-3.48(m,2H);13CNMR(100MHz,CDCl3):δ196.8,139.1,133.5,129.1,128.7,128.0,127.9,127.5,79.6,41.5,39.3. 1 H NMR (400MHz, CDCl 3 ): δ7.92-7.94(d, J=8Hz, 2H), 7.57-7.59(m, 1H), 7.45-7.48(m, 2H), 7.26-7.34(m, 5H ), 4.82-4.87(dd, J=6.4Hz, 12.4Hz, 1H), 4.67-4.72(dd, J=8.4Hz, 12.8Hz, 1H), 4.24(m, 1H), 3.45-3.48(m, 2H ); 13 CNMR (100MHz, CDCl 3 ): δ196.8, 139.1, 133.5, 129.1, 128.7, 128.0, 127.9, 127.5, 79.6, 41.5, 39.3.

红外光谱分析:3058,3029,2920,1687,1544,1440,1367,1268,1224,1084,988,764,703,623,559cm-1.Infrared spectrum analysis: 3058, 3029, 2920, 1687, 1544, 1440, 1367, 1268, 1224, 1084, 988, 764, 703, 623, 559cm -1 .

质谱分析:Mass Spectrometry:

ESI-MS:m/z 270[M+].ESI-MS: m/z 270[M + ].

实施例4:(S)-1-(3-甲苯基)-4-硝基-3-苯基-1-丁酮和(R)-1-(3-甲苯基)-4-硝基-3-苯基-1-丁酮结构式如下:Example 4: (S)-1-(3-methylphenyl)-4-nitro-3-phenyl-1-butanone and (R)-1-(3-methylphenyl)-4-nitro- The structural formula of 3-phenyl-1-butanone is as follows:

Figure C20081015014000131
Figure C20081015014000131

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-1-(3-甲苯基)-4-硝基-3-苯基-1-丁酮,制备过程中用间甲基苯乙酮40μl(0.3mmol)替代了实施例3中的35μl(0.3mmol)苯乙酮,其制备过程与实施例3相同。(S)-1-(3-甲苯基)-4-硝基-3-苯基-1-丁酮得到91%产率。a. Prepare (S)-1-(3-methylphenyl)-4-nitro-3-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, prepare In the process, 40 μl (0.3 mmol) of m-methylacetophenone was used to replace 35 μl (0.3 mmol) of acetophenone in Example 3, and the preparation process was the same as that of Example 3. (S)-1-(3-Tolyl)-4-nitro-3-phenyl-1-butanone was obtained in 91% yield.

[α]20 D=-10(c=0.6,CHCl3)。[α] 20 D = -10 (c = 0.6, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=9.80min,对映体选择性大于99%。High-performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane=15/85, 1.0mL/min, UV absorption 254nm.) t major =9.80min, enantioselectivity greater than 99%.

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-1-(3-甲苯基)-4-硝基-3-苯基-1-丁酮,制备过程中用间甲基苯乙酮40μl(0.3mmol)替代了实施例3中的35μl(0.3mmol)苯乙酮,其制备过程与实施例3相同。(R)-1-(3-甲苯基)-4-硝基-3-苯基-1-丁酮得到93%产率。b. Prepare (R)-1-(3-methylphenyl)-4-nitro-3-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU, prepare In the process, 40 μl (0.3 mmol) of m-methylacetophenone was used to replace 35 μl (0.3 mmol) of acetophenone in Example 3, and the preparation process was the same as that of Example 3. (R)-1-(3-Tolyl)-4-nitro-3-phenyl-1-butanone was obtained in 93% yield.

[α]20 D=+6(c=1.3,CHCl3)。[α] 20 D = +6 (c = 1.3, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=12.33min,tminor=9.90min,对映体选择性达到98%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 12.33min, t minor = 9.90min, Enantioselectivity reaches 98%.

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.71-7.72(m,2H),7.25-7.40(m,7H),4.81-4.86(dd,J=6.8Hz,12.8Hz,1H),4.67-4.71(dd,J=8.4Hz,12.8Hz,1H),4.21-4.24(m,1H),3.38-3.50(m,2H),2.40(s,3H);13C NMR(100MHz,CDCl3):δ196.99,139.2,138.6,136.5,134.3,129.0,128.6,128.5,127.8,127.4,125.2,79.6,41.6,39.3,21.3. 1 H NMR (400MHz, CDCl 3 ): δ7.71-7.72 (m, 2H), 7.25-7.40 (m, 7H), 4.81-4.86 (dd, J=6.8Hz, 12.8Hz, 1H), 4.67-4.71 (dd, J=8.4Hz, 12.8Hz, 1H), 4.21-4.24(m, 1H), 3.38-3.50(m, 2H), 2.40(s, 3H); 13 C NMR (100MHz, CDCl 3 ): δ196 .99, 139.2, 138.6, 136.5, 134.3, 129.0, 128.6, 128.5, 127.8, 127.4, 125.2, 79.6, 41.6, 39.3, 21.3.

红外光谱分析:3031,2920,1683,1551,1431,1378,1273,1160,980,767,698,562cm-1.Infrared spectrum analysis: 3031, 2920, 1683, 1551, 1431, 1378, 1273, 1160, 980, 767, 698, 562cm -1 .

高分辨质谱分析:High-resolution mass spectrometry analysis:

HRMS-ESI(m/z):calcd for C17H17NO3+NH4 +:301.1547;found:301.1547,0.0ppm.HRMS-ESI(m/z): calcd for C 17 H 17 NO 3 +NH 4 + : 301.1547; found: 301.1547, 0.0ppm.

实施例5:(S)-1-(3-溴苯基)-4-硝基-3-苯基-1-丁酮和(R)-1-(3-溴苯基)-4-硝基-3-苯基-1-丁酮结构式如下:Example 5: (S)-1-(3-bromophenyl)-4-nitro-3-phenyl-1-butanone and (R)-1-(3-bromophenyl)-4-nitro The structural formula of base-3-phenyl-1-butanone is as follows:

Figure C20081015014000141
Figure C20081015014000141

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-1-(3-溴苯基)-4-硝基-3-苯基-1-丁酮,制备过程中用间溴苯乙酮40μl(0.3mmol)替代了实施例3中的35μl(0.3mmol)苯乙酮,其制备过程与实施例3相同。(S)-1-(3-溴苯基)-4-硝基-3-苯基-1-丁酮得到96%产率。a. Prepare (S)-1-(3-bromophenyl)-4-nitro-3-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, In the preparation process, 40 μl (0.3 mmol) of m-bromoacetophenone was used instead of 35 μl (0.3 mmol) of acetophenone in Example 3, and the preparation process was the same as that of Example 3. (S)-1-(3-Bromophenyl)-4-nitro-3-phenyl-1-butanone was obtained in 96% yield.

[α]20 D=-13(c=1.7,CHCl3)。[α] 20 D = -13 (c = 1.7, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=11.65min,tminor=13.44min,对映体选择性达到98%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 11.65min, t minor = 13.44min, Enantioselectivity reaches 98%.

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-1-(3-溴苯基)-4-硝基-3-苯基-1-丁酮,制备过程中用间溴苯乙酮40μl(0.3mmol)替代了实施例3中的35μl(0.3mmol)苯乙酮,其制备过程与实施例3相同。(R)-1-(3-溴苯基)-4-硝基-3-苯基-1-丁酮得到91%产率。b. Prepare (R)-1-(3-bromophenyl)-4-nitro-3-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU, In the preparation process, 40 μl (0.3 mmol) of m-bromoacetophenone was used instead of 35 μl (0.3 mmol) of acetophenone in Example 3, and the preparation process was the same as that of Example 3. (R)-1-(3-Bromophenyl)-4-nitro-3-phenyl-1-butanone was obtained in 91% yield.

[α]20 D=+8(c=1.0,CHCl3)。[α] 20 D = +8 (c = 1.0, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=13.62min,tminor=11.78min,对映体选择性大于99%.。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 13.62min, t minor = 11.78min, Enantioselectivity greater than 99%..

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ8.03(s,1H),7.83-7.85(d,J=8.0Hz,1H),7.69-7.71(m,1H),7.24-7.36(m,6H),4.79-4.84(dd,J=7.2Hz,12.4Hz,1H),4.66-4.72(dd,J=8.0Hz,12.4Hz,1H),4.18-4.25(m,1H),3.37-3.49(m,2H);13C NMR(100MHz,CDCl3):δ195.5,138.8,138.1,136.4,131.1,130.3,129.1,128.0,127.4,126.5,123.1,79.4,41.6,39.2. 1 H NMR (400MHz, CDCl 3 ): δ8.03(s, 1H), 7.83-7.85(d, J=8.0Hz, 1H), 7.69-7.71(m, 1H), 7.24-7.36(m, 6H) , 4.79-4.84(dd, J=7.2Hz, 12.4Hz, 1H), 4.66-4.72(dd, J=8.0Hz, 12.4Hz, 1H), 4.18-4.25(m, 1H), 3.37-3.49(m, 2H); 13 C NMR (100MHz, CDCl 3 ): δ195.5, 138.8, 138.1, 136.4, 131.1, 130.3, 129.1, 128.0, 127.4, 126.5, 123.1, 79.4, 41.6, 39.2.

红外光谱分析:3064,3031,2922,2854,1689,1551,1420,1377,1201,1070,995,765,700,559cm-1.Infrared spectrum analysis: 3064, 3031, 2922, 2854, 1689, 1551, 1420, 1377, 1201, 1070, 995, 765, 700, 559cm -1 .

高分辨质谱分析:High-resolution mass spectrometry analysis:

HRMS-ESI(m/z):calcd for C16H14BrNO3+NH4 +:365.0495;found:365.0491,1.1ppm.HRMS-ESI(m/z): calcd for C 16 H 14 BrNO 3 +NH 4 + : 365.0495; found: 365.0491, 1.1ppm.

实施例6:(S)-1-(4-氯苯基)-4-硝基-3-苯基-1-丁酮和(R)-1-(4-氯苯基)-4-硝基-3-苯基-1-丁酮结构式如下:Example 6: (S)-1-(4-chlorophenyl)-4-nitro-3-phenyl-1-butanone and (R)-1-(4-chlorophenyl)-4-nitro The structural formula of base-3-phenyl-1-butanone is as follows:

Figure C20081015014000151
Figure C20081015014000151

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-1-(4-氯苯基)-4-硝基-3-苯基-1-丁酮,制备过程中用对氯苯乙酮39μl(0.3mmol)替代了实施例3中的35μl(0.3mmol)苯乙酮,其制备过程与实施例3相同。(S)-1-(4-氯苯基)-4-硝基-3-苯基-1-丁酮得到98%产率。a. Prepare (S)-1-(4-chlorophenyl)-4-nitro-3-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, In the preparation process, 39 μl (0.3 mmol) of p-chloroacetophenone was used instead of 35 μl (0.3 mmol) of acetophenone in Example 3, and the preparation process was the same as that of Example 3. (S)-1-(4-Chlorophenyl)-4-nitro-3-phenyl-1-butanone was obtained in 98% yield.

[α]20 D=-12(c=0.6,CHCl3)。[α] 20 D = -12 (c = 0.6, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=16.80min,tminor=21.32min,对映体选择性达到99%;High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 16.80min, t minor = 21.32min, Enantioselectivity reaches 99%;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-1-(4-氯苯基)-4-硝基-3-苯基-1-丁酮,制备过程中用对氯苯乙酮39μl(0.3mmol)替代了实施例3中的35μl(0.3mmol)苯乙酮,其制备过程与实施例3相同。(R)-1-(4-氯苯基)-4-硝基-3-苯基-1-丁酮得到97%产率。b. Prepare (R)-1-(4-chlorophenyl)-4-nitro-3-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU, In the preparation process, 39 μl (0.3 mmol) of p-chloroacetophenone was used instead of 35 μl (0.3 mmol) of acetophenone in Example 3, and the preparation process was the same as that of Example 3. (R)-1-(4-Chlorophenyl)-4-nitro-3-phenyl-1-butanone was obtained in 97% yield.

[α]20 D=+20(c=1.0,CHCl3)。[α] 20 D = +20 (c = 1.0, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=21.73min,tminor=16.52min,对映体选择性达到99%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 21.73min, t minor = 16.52min, Enantioselectivity reaches 99%.

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.85-7.87(d,J=8Hz,2H),7.26-7.44(m,7H),4.80-4.85(dd,J=7.2Hz,12.4Hz,1H),4.67-4.71(dd,J=8.4Hz,12.8Hz,1H),4.18-4.25(m,1H),3.37-3.47(m,2H);13C NMR(100MHz,CDCl3):δ195.6,140.1,138.9,134.7,129.4,129.1,129.0,127.9,127.4,79.5,41.5,39.3.红外光谱分析:3064,2921,1685,1589,1551,1492,1378,1205,1092,993,822,764,701,529cm-1. 1 H NMR (400MHz, CDCl 3 ): δ7.85-7.87 (d, J=8Hz, 2H), 7.26-7.44 (m, 7H), 4.80-4.85 (dd, J=7.2Hz, 12.4Hz, 1H) , 4.67-4.71 (dd, J=8.4Hz, 12.8Hz, 1H), 4.18-4.25 (m, 1H), 3.37-3.47 (m, 2H); 13 C NMR (100MHz, CDCl 3 ): δ195.6, 140.1, 138.9, 134.7, 129.4, 129.1, 129.0, 127.9, 127.4, 79.5, 41.5, 39.3. Infrared spectrum analysis: 3064, 2921, 1685, 1589, 1551, 1492, 1378, 1205, 1092, 993, 822, 764, 701,529cm -1 .

质谱分析:Mass Spectrometry:

ESI-MS:m/z 304[M+].ESI-MS: m/z 304 [M + ].

实施例7:(S)-1-(4-甲氧苯基)-4-硝基-3-苯基-1-丁酮和(R)-1-(4-甲氧苯基)-4-硝基-3-苯基-1-丁酮结构式如下:Example 7: (S)-1-(4-methoxyphenyl)-4-nitro-3-phenyl-1-butanone and (R)-1-(4-methoxyphenyl)-4 -Nitro-3-phenyl-1-butanone structural formula is as follows:

Figure C20081015014000161
Figure C20081015014000161

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-1-(4-甲氧苯基)-4-硝基-3-苯基-1-丁酮,制备过程中用对甲氧基苯乙酮45mg(0.3mmol)替代了实施例3中的35μl(0.3mmol)苯乙酮,其制备过程与实施例3相同。a. Preparation of (S)-1-(4-methoxyphenyl)-4-nitro-3-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU In the preparation process, 45 mg (0.3 mmol) of p-methoxyacetophenone was used to replace 35 μl (0.3 mmol) of acetophenone in Example 3, and the preparation process was the same as in Example 3.

(S)-1-(4-甲氧苯基)-4-硝基-3-苯基-1-丁酮得到80%产率。(S)-1-(4-Methoxyphenyl)-4-nitro-3-phenyl-1-butanone was obtained in 80% yield.

[α]20 D=-25(c=0.7,CHCl3);熔点:64-65℃。[α] 20 D = -25 (c = 0.7, CHCl 3 ); melting point: 64-65°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=35/65,1.0mL/min,紫外吸收254nm.)tmajor=12.82min,对映体选择性大于99%;High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane=35/65, 1.0mL/min, UV absorption 254nm.) t major =12.82min, enantioselectivity greater than 99%;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-1-(4-甲氧苯基)-4-硝基-3-苯基-1-丁酮,制备过程中用对甲氧基苯乙酮45mg(0.3mmol)替代了实施例3中的35μl(0.3mmol)苯乙酮,其制备过程与实施例3相同。b. Preparation of (R)-1-(4-methoxyphenyl)-4-nitro-3-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU In the preparation process, 45 mg (0.3 mmol) of p-methoxyacetophenone was used to replace 35 μl (0.3 mmol) of acetophenone in Example 3, and the preparation process was the same as in Example 3.

(R)-1-(4-甲氧苯基)-4-硝基-3-苯基-1-丁酮得到80%产率。(R)-1-(4-Methoxyphenyl)-4-nitro-3-phenyl-1-butanone was obtained in 80% yield.

[α]20 D=+8(c=1.0,CHCl3);熔点:65℃。[α] 20 D = +8 (c = 1.0, CHCl 3 ); melting point: 65°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=35/65,1.0mL/min,紫外吸收254nm.)tmajor=18.32min,tminor=11.96min,对映体选择性达到98%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 35/65, 1.0mL/min, UV absorption 254nm.) t major = 18.32min, t minor = 11.96min, Enantioselectivity reaches 98%.

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.89-7.91(d,J=8.4Hz,2H),7.25-7.35(m,5H),6.91-6.93(d,J=8.8Hz,2H),4.82-4.87(dd,J=6.4Hz,12.4Hz,1H),4.66-4.71(dd,J=8.4Hz,12.4Hz,1H),4.20-4.23(m,1H),3.87(s,3H),3.33-3.45(m,2H);13C NMR(100MHz,CDCl3):δ195.3,163.9,139.3,130.3,129.5,129.0,127.8,127.4,79.6,55.5,41.2,39.5. 1 H NMR (400MHz, CDCl 3 ): δ7.89-7.91 (d, J=8.4Hz, 2H), 7.25-7.35 (m, 5H), 6.91-6.93 (d, J=8.8Hz, 2H), 4.82 -4.87(dd, J=6.4Hz, 12.4Hz, 1H), 4.66-4.71(dd, J=8.4Hz, 12.4Hz, 1H), 4.20-4.23(m, 1H), 3.87(s, 3H), 3.33 -3.45 (m, 2H); 13 C NMR (100MHz, CDCl 3 ): δ195.3, 163.9, 139.3, 130.3, 129.5, 129.0, 127.8, 127.4, 79.6, 55.5, 41.2, 39.5.

红外光谱分析:3062,2923,2845,1675,1600,1551,1511,1420,1377,1262,1172,1027,833,701,557cm-1.Infrared spectral analysis: 3062, 2923, 2845, 1675, 1600, 1551, 1511, 1420, 1377, 1262, 1172, 1027, 833, 701, 557cm -1 .

高分辨质谱分析:High-resolution mass spectrometry analysis:

HRMS-ESI(m/z):calcd for C17H17NO4[M+H]+:300.1230;found:300.1233,1.0ppm.HRMS-ESI(m/z): calcd for C 17 H 17 NO 4 [M+H] + : 300.1230; found: 300.1233, 1.0ppm.

实施例8:(S)-3-(4-氯苯基)-4-硝基-1-苯基-1-丁酮和(R)-3-(4-氯苯基)-4-硝基-1-苯基-1-丁酮结构式如下:Example 8: (S)-3-(4-chlorophenyl)-4-nitro-1-phenyl-1-butanone and (R)-3-(4-chlorophenyl)-4-nitro The structural formula of base-1-phenyl-1-butanone is as follows:

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-3-(4-氯苯基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基对氯苯乙烯18.4mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(S)-3-(4-氯苯基)-4-硝基-1-苯基-1-丁酮得到92%产率。a. Prepare (S)-3-(4-chlorophenyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, In the preparation process, 18.4 mg (0.1 mmol) of nitro-p-chlorostyrene was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 3, and the preparation process was the same as in Example 3. (S)-3-(4-Chlorophenyl)-4-nitro-1-phenyl-1-butanone was obtained in 92% yield.

[α]20 D=-28(c=1.2,CHCl3);熔点:78-79℃。[α] 20 D = -28 (c = 1.2, CHCl 3 ); melting point: 78-79°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=14.51min,对映体选择性大于99%;High-performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane=15/85, 1.0mL/min, UV absorption 254nm.) t major =14.51min, enantioselectivity greater than 99%;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-3-(4-氯苯基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基对氯苯乙烯18.4mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(R)-3-(4-氯苯基)-4-硝基-1-苯基-1-丁酮得到88%产率。b. Prepare (R)-3-(4-chlorophenyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU, In the preparation process, 18.4 mg (0.1 mmol) of nitro-p-chlorostyrene was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 3, and the preparation process was the same as in Example 3. (R)-3-(4-Chlorophenyl)-4-nitro-1-phenyl-1-butanone was obtained in 88% yield.

[α]20 D=+10(c=1.0,CHCl3);熔点:78-79℃。[α] 20 D = +10 (c = 1.0, CHCl 3 ); melting point: 78-79°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=20.62min,tminor=14.72min,对映体选择性大于99%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 20.62min, t minor = 14.72min, Enantioselectivity greater than 99%.

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.88-7.91(m,2H),7.55-7.59(m,1H),7.43-7.50(m,2H),7.28-7.31(m,2H),7.19-7.25(m,2H),4.78-4.82(dd,J=6.4Hz,12.4Hz,1H),4.62-4.67(dd,J=8.4Hz,12.8Hz,1H),4.16-4.24(m,1H),3.36-3.47(m,2H);13C NMR(100MHz,CDCl3):δ196.5,137.5,136.2,133.7,129.2,128.9,128.8,128.0,79.3,41.3,38.7. 1 H NMR (400MHz, CDCl 3 ): δ7.88-7.91(m, 2H), 7.55-7.59(m, 1H), 7.43-7.50(m, 2H), 7.28-7.31(m, 2H), 7.19- 7.25(m, 2H), 4.78-4.82(dd, J=6.4Hz, 12.4Hz, 1H), 4.62-4.67(dd, J=8.4Hz, 12.8Hz, 1H), 4.16-4.24(m, 1H), 3.36-3.47 (m, 2H); 13 C NMR (100MHz, CDCl 3 ): δ196.5, 137.5, 136.2, 133.7, 129.2, 128.9, 128.8, 128.0, 79.3, 41.3, 38.7.

红外光谱分析:3063,2922,2853,2255,1684,1551,1492,1445,1376,1228,1093,1008,909,828,733,688,546cm-1.Infrared spectral analysis: 3063, 2922, 2853, 2255, 1684, 1551, 1492, 1445, 1376, 1228, 1093, 1008, 909, 828, 733, 688, 546cm -1 .

质谱分析:Mass Spectrometry:

ESI-MS:m/z 304[M+].ESI-MS: m/z 304 [M + ].

实施例9:(S)-3-(3-氯苯基)-4-硝基-1-苯基-1-丁酮和(R)-3-(3-氯苯基)-4-硝基-1-苯基-1-丁酮结构式如下:Example 9: (S)-3-(3-chlorophenyl)-4-nitro-1-phenyl-1-butanone and (R)-3-(3-chlorophenyl)-4-nitro The structural formula of base-1-phenyl-1-butanone is as follows:

Figure C20081015014000181
Figure C20081015014000181

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-3-(3-氯苯基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基间氯苯乙烯18.4mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(S)-3-(3-氯苯基)-4-硝基-1-苯基-1-丁酮得到99%产率。a. Prepare (S)-3-(3-chlorophenyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, In the preparation process, 18.4 mg (0.1 mmol) of nitro-m-chlorostyrene was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 3, and the preparation process was the same as in Example 3. (S)-3-(3-Chlorophenyl)-4-nitro-1-phenyl-1-butanone was obtained in 99% yield.

[α]20 D=-20(c=1.4,CHCl3)。[α] 20 D = -20 (c = 1.4, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=10.11min,对映体选择性大于99%.;High-performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane=15/85, 1.0mL/min, UV absorption 254nm.) t major =10.11min, enantioselectivity greater than 99%.;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-3-(3-氯苯基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基间氯苯乙烯18.4mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(R)-3-(3-氯苯基)-4-硝基-1-苯基-1-丁酮得到99%产率。b. Prepare (R)-3-(3-chlorophenyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU, In the preparation process, 18.4 mg (0.1 mmol) of nitro-m-chlorostyrene was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 3, and the preparation process was the same as in Example 3. (R)-3-(3-Chlorophenyl)-4-nitro-1-phenyl-1-butanone was obtained in 99% yield.

[α]20 D=+14(c=1.1,CHCl3)。[α] 20 D = +14 (c = 1.1, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=12.16min,tminor=10.08min,对映体选择性达到99%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 12.16min, t minor = 10.08min, Enantioselectivity reaches 99%.

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.94-7.96(d,J=7.2Hz,2H),7.57-7.61(m,1H),7.41-7.49(m,3H),7.20-7.31(m,3H),4.84-4.90(m,2H),4.66-4.73(m,1H)3.51-3.62(m,2H);13C NMR(100MHz,CDCl3):δ196.7,136.2,133.8,133.6,130.5,129.0,128.7,128.5,128.0,127.4,77.5,39.9,36.1. 1 H NMR (400MHz, CDCl 3 ): δ7.94-7.96 (d, J=7.2Hz, 2H), 7.57-7.61 (m, 1H), 7.41-7.49 (m, 3H), 7.20-7.31 (m, 3H), 4.84-4.90 (m, 2H), 4.66-4.73 (m, 1H) 3.51-3.62 (m, 2H); 13 C NMR (100MHz, CDCl 3 ): δ196.7, 136.2, 133.8, 133.6, 130.5 , 129.0, 128.7, 128.5, 128.0, 127.4, 77.5, 39.9, 36.1.

红外光谱分析:3063,2918,2852,1684,1551,1477,1444,1377,1228,1038,998,755,689,560cm-1.Infrared spectrum analysis: 3063, 2918, 2852, 1684, 1551, 1477, 1444, 1377, 1228, 1038, 998, 755, 689, 560cm -1 .

高分辨质谱分析:High-resolution mass spectrometry analysis:

HRMS-ESI(m/z):calcd for C16H14ClNO3+NH4 +:321.1000;found:321.0992,2.5ppm.HRMS-ESI (m/z): calcd for C 16 H 14 ClNO 3 +NH 4 + : 321.1000; found: 321.0992, 2.5ppm.

实施例10:(S)-3-(2-氯苯基)-4-硝基-1-苯基-1-丁酮和(R)-3-(2-氯苯基)-4-硝基-1-苯基-1-丁酮结构式如下:Example 10: (S)-3-(2-chlorophenyl)-4-nitro-1-phenyl-1-butanone and (R)-3-(2-chlorophenyl)-4-nitro The structural formula of base-1-phenyl-1-butanone is as follows:

Figure C20081015014000191
Figure C20081015014000191

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-3-(2-氯苯基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基邻氯苯乙烯18.4mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(S)-3-(2-氯苯基)-4-硝基-1-苯基-1-丁酮得到99%产率。a. Prepare (S)-3-(2-chlorophenyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, In the preparation process, 18.4 mg (0.1 mmol) of nitro-o-chlorostyrene was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 3, and the preparation process was the same as in Example 3. (S)-3-(2-Chlorophenyl)-4-nitro-1-phenyl-1-butanone was obtained in 99% yield.

[α]20 D=-18(c=1.4,CHCl3);熔点:77-78℃。[α] 20 D = -18 (c = 1.4, CHCl 3 ); melting point: 77-78°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=11.81min,对映体选择性大于99%;High-performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane=15/85, 1.0mL/min, UV absorption 254nm.) t major =11.81min, enantioselectivity greater than 99%;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-3-(2-氯苯基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基邻氯苯乙烯18.4mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(R)-3-(2-氯苯基)-4-硝基-1-苯基-1-丁酮得到94%产率。b. Prepare (R)-3-(2-chlorophenyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU, In the preparation process, 18.4 mg (0.1 mmol) of nitro-o-chlorostyrene was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 3, and the preparation process was the same as in Example 3. (R)-3-(2-Chlorophenyl)-4-nitro-1-phenyl-1-butanone was obtained in 94% yield.

[α]20 D=+8(c=1.6,CHCl3);熔点:77-79℃。[α] 20 D = +8 (c = 1.6, CHCl 3 ); melting point: 77-79°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=13.80min,tminor=11.68min,对映体选择性大于99%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 13.80min, t minor = 11.68min, Enantioselectivity greater than 99%.

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.92-7.94(m,2H),7.55-7.59(m,1H),7.39-7.47(m,3H),7.19-7.29(m,3H),4.85-4.87(m,2H),4.65-4.71(m,1H)3.50-3.60(m,2H);13C NMR(100MHz,CDCl3):δ196.7,136.2,133.8,133.6,130.4,129.0,128.7,128.4,128.0,127.4,77.5,39.8,36.1. 1 H NMR (400MHz, CDCl 3 ): δ7.92-7.94(m, 2H), 7.55-7.59(m, 1H), 7.39-7.47(m, 3H), 7.19-7.29(m, 3H), 4.85- 4.87 (m, 2H), 4.65-4.71 (m, 1H) 3.50-3.60 (m, 2H); 13 C NMR (100MHz, CDCl 3 ): δ196.7, 136.2, 133.8, 133.6, 130.4, 129.0, 128.7, 128.4, 128.0, 127.4, 77.5, 39.8, 36.1.

红外光谱分析:3063,2918,1684,1596,1551,1477,1442,1376,1228,1039,998,755,689,560cm-1.Infrared spectrum analysis: 3063, 2918, 1684, 1596, 1551, 1477, 1442, 1376, 1228, 1039, 998, 755, 689, 560cm -1 .

质谱分析:Mass Spectrometry:

ESI-MS:m/z 304[M+].ESI-MS: m/z 304 [M + ].

实施例11:(S)-3-(2-甲氧苯基)-4-硝基-1-苯基-1-丁酮和(R)-3-(2-甲氧苯基)-4-硝基-1-苯基-1-丁酮结构式如下:Example 11: (S)-3-(2-methoxyphenyl)-4-nitro-1-phenyl-1-butanone and (R)-3-(2-methoxyphenyl)-4 -Nitro-1-phenyl-1-butanone structural formula is as follows:

Figure C20081015014000201
Figure C20081015014000201

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-3-(2-甲氧苯基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基邻甲氧基苯乙烯17.9mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(S)-3-(2-甲氧苯基)-4-硝基-1-苯基-1-丁酮得到86%产率。a. Preparation of (S)-3-(2-methoxyphenyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU 15 mg (0.1 mmol) of nitrostyrene in Example 3 was replaced with 17.9 mg (0.1 mmol) of nitro-o-methoxystyrene in the preparation process, and the preparation process was the same as in Example 3. (S)-3-(2-Methoxyphenyl)-4-nitro-1-phenyl-1-butanone was obtained in 86% yield.

[α]20 D=-8(c=1.2,CHCl3)。[α] 20 D = -8 (c = 1.2, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=10.98min,tminor=14.80min,对映体选择性达到99%;High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 10.98min, t minor = 14.80min, Enantioselectivity reaches 99%;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-3-(2-甲氧苯基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基邻甲氧基苯乙烯17.9mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(R)-3-(2-甲氧苯基)-4-硝基-1-苯基-1-丁酮得到82%产率。b. Preparation of (R)-3-(2-methoxyphenyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU 15 mg (0.1 mmol) of nitrostyrene in Example 3 was replaced with 17.9 mg (0.1 mmol) of nitro-o-methoxystyrene in the preparation process, and the preparation process was the same as in Example 3. (R)-3-(2-Methoxyphenyl)-4-nitro-1-phenyl-1-butanone was obtained in 82% yield.

[α]20 D=+5(c=1.4,CHCl3)。[α] 20 D = +5 (c = 1.4, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=16.65min,tminor=12.24min,对映体选择性达到98%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 16.65min, t minor = 12.24min, Enantioselectivity reaches 98%.

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.91-7.93(m,2H),7.53-7.57(m,1H),7.42-7.46(m,2H),7.18-7.25(m,2H),6.86-6.91(m,2H),4.83-4.86(m,2H),4.38-4.42(m,1H),3.85(s,3H),3.51-3.53(m,2H);13C NMR(100MHz,CDCl3):δ197.6,157.1,136.6,133.3,129.5,128.9,128.6,128.0,126.6,120.9,110.98,77.8,55.3,39.7,35.9. 1 H NMR (400MHz, CDCl 3 ): δ7.91-7.93(m, 2H), 7.53-7.57(m, 1H), 7.42-7.46(m, 2H), 7.18-7.25(m, 2H), 6.86- 6.91(m, 2H), 4.83-4.86(m, 2H), 4.38-4.42(m, 1H), 3.85(s, 3H), 3.51-3.53(m, 2H); 13 C NMR (100MHz, CDCl 3 ) : δ197.6, 157.1, 136.6, 133.3, 129.5, 128.9, 128.6, 128.0, 126.6, 120.9, 110.98, 77.8, 55.3, 39.7, 35.9.

红外光谱分析:3063,2923,2852,1684,1598,1550,1494,1445,1377,1246,1120,1025,754,690cm-1.Infrared spectrum analysis: 3063, 2923, 2852, 1684, 1598, 1550, 1494, 1445, 1377, 1246, 1120, 1025, 754, 690cm -1 .

高分辨质谱分析:High-resolution mass spectrometry analysis:

HRMS-ESI(m/z):calcd for C17H17NO4+NH4 +:317.1496;found:317.1498,0.6ppm.HRMS-ESI(m/z): calcd for C 17 H 17 NO 4 +NH 4 + : 317.1496; found: 317.1498, 0.6ppm.

实施例12:(S)-3-(4-甲氧苯基)-4-硝基-1-苯基-1-丁酮和(R)-3-(4-甲氧苯基)-4-硝基-1-苯基-1-丁酮结构式如下:Example 12: (S)-3-(4-methoxyphenyl)-4-nitro-1-phenyl-1-butanone and (R)-3-(4-methoxyphenyl)-4 -Nitro-1-phenyl-1-butanone structural formula is as follows:

Figure C20081015014000211
Figure C20081015014000211

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-3-(4-甲氧苯基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基对甲氧基苯乙烯17.9mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(S)-3-(4-甲氧苯基)-4-硝基-1-苯基-1-丁酮得到81%产率。a. Preparation of (S)-3-(4-methoxyphenyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU 15 mg (0.1 mmol) of nitrostyrene in Example 3 was replaced with 17.9 mg (0.1 mmol) of nitro-p-methoxystyrene in the preparation process, and the preparation process was the same as in Example 3. (S)-3-(4-Methoxyphenyl)-4-nitro-1-phenyl-1-butanone was obtained in 81% yield.

[α]20 D=-20(c=1.0,CHCl3);熔点:71℃。[α] 20 D = -20 (c = 1.0, CHCl 3 ); melting point: 71°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=15.67min,对映体选择性大于99%;High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane=15/85, 1.0mL/min, UV absorption 254nm.) t major =15.67min, enantioselectivity greater than 99%;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-3-(4-甲氧苯基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基对甲氧基苯乙烯17.9mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(R)-3-(4-甲氧苯基)-4-硝基-1-苯基-1-丁酮得到80%产率。b. Preparation of (R)-3-(4-methoxyphenyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU 15 mg (0.1 mmol) of nitrostyrene in Example 3 was replaced with 17.9 mg (0.1 mmol) of nitro-p-methoxystyrene in the preparation process, and the preparation process was the same as in Example 3. (R)-3-(4-Methoxyphenyl)-4-nitro-1-phenyl-1-butanone was obtained in 80% yield.

[α]20 D=+12(c=1.0,CHCl3);熔点:72-73℃。[α] 20 D = +12 (c = 1.0, CHCl 3 ); melting point: 72-73°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=21.84min,对映体选择性大于99%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane=15/85, 1.0mL/min, UV absorption 254nm.) t major =21.84min, enantioselectivity greater than 99%.

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.89-7.91(d,J=7.6Hz,2H),7.54-7.58(m,1H),7.42-7.46(m,2H),7.17-7.19(d,J=7.6Hz,2H),6.83-6.85(d,J=6.8Hz,2H),4.76-4.80(dd,J=6.4Hz,12.0Hz,1H),4.60-4.65(m,1H),4.14-4.18(m,1H),3.75(s,3H),3.39-3.47(m,2H);13C NMR(100MHz,CDCl3):δ196.9,159.0,136.4,133.5,130.9,128.7,128.5,127.99,114.4,79.8,55.2,41.6,38.6. 1 H NMR (400MHz, CDCl 3 ): δ7.89-7.91(d, J=7.6Hz, 2H), 7.54-7.58(m, 1H), 7.42-7.46(m, 2H), 7.17-7.19(d, J=7.6Hz, 2H), 6.83-6.85(d, J=6.8Hz, 2H), 4.76-4.80(dd, J=6.4Hz, 12.0Hz, 1H), 4.60-4.65(m, 1H), 4.14- 4.18 (m, 1H), 3.75 (s, 3H), 3.39-3.47 (m, 2H); 13 C NMR (100MHz, CDCl 3 ): δ196.9, 159.0, 136.4, 133.5, 130.9, 128.7, 128.5, 127.99 , 114.4, 79.8, 55.2, 41.6, 38.6.

红外光谱分析:3033,2919,2839,1684,1610,1551,1514,1446,1377,1251,1181,1032,832,754,692,555cm-1.Infrared spectral analysis: 3033, 2919, 2839, 1684, 1610, 1551, 1514, 1446, 1377, 1251, 1181, 1032, 832, 754, 692, 555cm -1 .

质谱分析:Mass Spectrometry:

ESI-MS:m/z 300[M+].ESI-MS: m/z 300[M + ].

实施例13:(S)-3-(4-甲苯基)-4-硝基-1-苯基-1-丁酮和(R)-3-(4-甲苯基)-4-硝基-1-苯基-1-丁酮结构式如下:Example 13: (S)-3-(4-methylphenyl)-4-nitro-1-phenyl-1-butanone and (R)-3-(4-methylphenyl)-4-nitro- The structural formula of 1-phenyl-1-butanone is as follows:

Figure C20081015014000212
Figure C20081015014000212

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-3-(4-甲苯基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基对甲基苯乙烯16.3mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(S)-3-(4-甲苯基)-4-硝基-1-苯基-1-丁酮得到81%产率。a. Prepare (S)-3-(4-methylphenyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, prepare In the process, 16.3 mg (0.1 mmol) of nitro-p-methylstyrene was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 3, and the preparation process was the same as in Example 3. (S)-3-(4-Tolyl)-4-nitro-1-phenyl-1-butanone was obtained in 81% yield.

[α]20 D=-20(c=1.8,CHCl3);熔点:83-85℃。[α] 20 D = -20 (c = 1.8, CHCl 3 ); melting point: 83-85°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=11.07min,对映体选择性大于99%;High-performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane=15/85, 1.0mL/min, UV absorption 254nm.) t major =11.07min, enantioselectivity greater than 99%;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-3-(4-甲苯基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基对甲基苯乙烯16.3mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(R)-3-(4-甲苯基)-4-硝基-1-苯基-1-丁酮得到82%产率。b. Prepare (R)-3-(4-methylphenyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU, prepare In the process, 16.3 mg (0.1 mmol) of nitro-p-methylstyrene was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 3, and the preparation process was the same as in Example 3. (R)-3-(4-Tolyl)-4-nitro-1-phenyl-1-butanone was obtained in 82% yield.

[α]20 D=+16(c=0.8,CHCl3);熔点:84-86℃。[α] 20 D = +16 (c = 0.8, CHCl 3 ); melting point: 84-86°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=14.28min,tminor=10.76min,对映体选择性达到98%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 14.28min, t minor = 10.76min, Enantioselectivity reaches 98%.

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.91-7.93(d,J=8.4Hz,2H),7.55-7.59(m,1H),7.47-7.43(m,2H),7.12-7.25(m,4H),4.78-4.83(dd,J=6.4Hz,12.4Hz,1H),4.63-4.68(dd,J=8.0Hz,12.8Hz,1H),4.17-4.22(dd,J=7.2Hz,14Hz,1H),3.37-3.49(m,2H),2.307(s,3H);13C NMR(100MHz,CDCl3):δ196.9,137.5,136.4,136.0,133.5,129.7,128.7,128.0,127.3,79.7,41.6,38.9,21.0. 1 H NMR (400MHz, CDCl 3 ): δ7.91-7.93 (d, J=8.4Hz, 2H), 7.55-7.59 (m, 1H), 7.47-7.43 (m, 2H), 7.12-7.25 (m, 4H), 4.78-4.83(dd, J=6.4Hz, 12.4Hz, 1H), 4.63-4.68(dd, J=8.0Hz, 12.8Hz, 1H), 4.17-4.22(dd, J=7.2Hz, 14Hz, 1H), 3.37-3.49(m, 2H), 2.307(s, 3H); 13 C NMR (100MHz, CDCl 3 ): δ196.9, 137.5, 136.4, 136.0, 133.5, 129.7, 128.7, 128.0, 127.3, 79.7 , 41.6, 38.9, 21.0.

红外光谱分析:3058,2922,2862,1685,1551,1516,1446,1377,1270,1225,998,817,755,691,551cm-1.Infrared spectral analysis: 3058, 2922, 2862, 1685, 1551, 1516, 1446, 1377, 1270, 1225, 998, 817, 755, 691, 551cm -1 .

质谱分析:Mass Spectrometry:

ESI-MS:m/z 284[M+].ESI-MS: m/z 284[M + ].

实施例14:(S)-3-(2-萘基)-4-硝基-1-苯基-1-丁酮和(R)-3-(2-萘基)-4-硝基-1-苯基-1-丁酮结构式如下:Example 14: (S)-3-(2-naphthyl)-4-nitro-1-phenyl-1-butanone and (R)-3-(2-naphthyl)-4-nitro- The structural formula of 1-phenyl-1-butanone is as follows:

Figure C20081015014000221
Figure C20081015014000221

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-3-(2-萘基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基-2-萘乙烯20mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(S)-3-(2-萘基)-4-硝基-1-苯基-1-丁酮得到83%产率。a. Prepare (S)-3-(2-naphthyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, prepare In the process, 20 mg (0.1 mmol) of nitro-2-naphthylethylene was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 3, and the preparation process was the same as in Example 3. (S)-3-(2-Naphthyl)-4-nitro-1-phenyl-1-butanone was obtained in 83% yield.

[α]20 D=-14(c=1.3,CHCl3);熔点:130-132℃。[α] 20 D = -14 (c = 1.3, CHCl 3 ); melting point: 130-132°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=15.72min,tminor=19.32min,对映体选择性大于99%;High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 15.72min, t minor = 19.32min, Enantioselectivity greater than 99%;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-3-(2-萘基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基-2-萘乙烯20mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(R)-3-(2-萘基)-4-硝基-1-苯基-1-丁酮得到80%产率。b. Prepare (R)-3-(2-naphthyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU, prepare In the process, 20 mg (0.1 mmol) of nitro-2-naphthylethylene was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 3, and the preparation process was the same as in Example 3. (R)-3-(2-Naphthyl)-4-nitro-1-phenyl-1-butanone was obtained in 80% yield.

[α]20 D=+16(c=1.6,CHCl3);熔点:130-132℃。[α] 20 D = +16 (c = 1.6, CHCl 3 ); melting point: 130-132°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=19.70min,tminor=15.70min,对映体选择性大于99%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 19.70min, t minor = 15.70min, Enantioselectivity greater than 99%.

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.90-7.93(m,2H),7.77-7.83(m,3H),7.72(s,1H),7.54-7.58(m,1H),7.24-7.49(m,5H),4.88-4.93(dd,J=6.8Hz,12.4Hz,1H),4.75-4.80(dd,J=8.0Hz,12.4Hz,1H),4.36-4.43(m,1H),3.47-3.60(m,2H);13C NMR(100MHz,CDCl3):δ196.8,136.5,133.6,133.4,132.8,128.97,128.7,128.0,127.8,127.7,126.5,126.4,126.2,125.1,79.4,41.6,39.4. 1 H NMR (400MHz, CDCl 3 ): δ7.90-7.93(m, 2H), 7.77-7.83(m, 3H), 7.72(s, 1H), 7.54-7.58(m, 1H), 7.24-7.49( m, 5H), 4.88-4.93(dd, J=6.8Hz, 12.4Hz, 1H), 4.75-4.80(dd, J=8.0Hz, 12.4Hz, 1H), 4.36-4.43(m, 1H), 3.47- 3.60 (m, 2H); 13 C NMR (100MHz, CDCl 3 ): δ196.8, 136.5, 133.6, 133.4, 132.8, 128.97, 128.7, 128.0, 127.8, 127.7, 126.5, 126.4, 126.2, 125.1, 79.4, 41.6 , 39.4.

红外光谱分析:3353,3056,2921,2853,1684,1550,1445,1445,1377,1273,1222,997,819,751,689,479cm-1.Infrared spectral analysis: 3353, 3056, 2921, 2853, 1684, 1550, 1445, 1445, 1377, 1273, 1222, 997, 819, 751, 689, 479cm -1 .

质谱分析:Mass Spectrometry:

ESI-MS:m/z 320[M+].ESI-MS: m/z 320[M + ].

实施例15:(S)-3-(2-呋喃基)-4-硝基-1-苯基-1-丁酮和(R)-3-(2-呋喃基)-4-硝基-1-苯基-1-丁酮结构式如下:Example 15: (S)-3-(2-furyl)-4-nitro-1-phenyl-1-butanone and (R)-3-(2-furyl)-4-nitro- The structural formula of 1-phenyl-1-butanone is as follows:

Figure C20081015014000231
Figure C20081015014000231

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-3-(2-呋喃基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基-2-呋喃乙烯14mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。(S)-3-(2-呋喃基)-4-硝基-1-苯基-1-丁酮有91%产率。a. Prepare (S)-3-(2-furyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, prepare In the process, 14 mg (0.1 mmol) of nitro-2-furan vinyl was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 3, and the preparation process was the same as that of Example 3. (S)-3-(2-Furyl)-4-nitro-1-phenyl-1-butanone in 91% yield.

[α]20 D=-16(c=0.6,CHCl3);熔点:33-35℃。[α] 20 D = -16 (c = 0.6, CHCl 3 ); melting point: 33-35°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=11.05min,tminor=13.36min,对映体选择性达到98%;High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 11.05min, t minor = 13.36min, Enantioselectivity reaches 98%;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-3-(2-呋喃基)-4-硝基-1-苯基-1-丁酮,制备过程中用硝基-2-呋喃乙烯14mg(0.1mmol)替代了实施例3中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例3相同。b. Prepare (R)-3-(2-furyl)-4-nitro-1-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU, prepare In the process, 14 mg (0.1 mmol) of nitro-2-furan vinyl was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 3, and the preparation process was the same as that of Example 3.

(R)-3-(2-呋喃基)-4-硝基-1-苯基-1-丁酮得到93%产率。(R)-3-(2-furyl)-4-nitro-1-phenyl-1-butanone was obtained in 93% yield.

[α]20 D=+6(c=0.8,CHCl3);熔点:33-35℃。[α] 20 D = +6 (c = 0.8, CHCl 3 ); melting point: 33-35°C.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收254nm.)tmajor=13.02min,tminor=10.81min,对映体选择性达到99%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 254nm.) t major = 13.02min, t minor = 10.81min, Enantioselectivity reaches 99%.

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.95-7.97(d,J=7.6Hz,2H),7.50-7.62(m,1H),7.46-7.48(m,2H),7.35(m,1H),6.29-6.30(d,J=3.2Hz,1H),6.19-6.20(d,J=3.2Hz,1H),4.73-4.84(m,2H),4.33-4.36(m,1H),3.41-3.56(m,2H);13C NMR(100MHz,CDCl3):δ196.5,151.9,142.3,136.3,133.6,128.7,128.0,110.5,107.2,77.2,38.96,33.2. 1 H NMR (400MHz, CDCl 3 ): δ7.95-7.97(d, J=7.6Hz, 2H), 7.50-7.62(m, 1H), 7.46-7.48(m, 2H), 7.35(m, 1H) , 6.29-6.30(d, J=3.2Hz, 1H), 6.19-6.20(d, J=3.2Hz, 1H), 4.73-4.84(m, 2H), 4.33-4.36(m, 1H), 3.41-3.56 (m, 2H); 13 C NMR (100MHz, CDCl 3 ): δ196.5, 151.9, 142.3, 136.3, 133.6, 128.7, 128.0, 110.5, 107.2, 77.2, 38.96, 33.2.

红外光谱分析:3121,3062,2918,1685,1596,1553,1505,1448,1377,1213,1183,1012,917,749,691,599cm-1.Infrared spectral analysis: 3121, 3062, 2918, 1685, 1596, 1553, 1505, 1448, 1377, 1213, 1183, 1012, 917, 749, 691, 599cm -1 .

高分辨质谱分析:High-resolution mass spectrometry analysis:

HRMS-ESI(m/z):calcd for C14H13NO4+NH4 +:277.1183;found:277.1187,1.4ppm.HRMS-ESI (m/z): calcd for C 14 H 13 NO 4 +NH 4 + : 277.1183; found: 277.1187, 1.4ppm.

实施例16:(S)-1-(2-呋喃基)-4-硝基-3-苯基-1-丁酮和(R)-1-(2-呋喃基)-4-硝基-3-苯基-1-丁酮结构式如下:Example 16: (S)-1-(2-furyl)-4-nitro-3-phenyl-1-butanone and (R)-1-(2-furyl)-4-nitro- The structural formula of 3-phenyl-1-butanone is as follows:

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-1-(2-呋喃基)-4-硝基-3-苯基-1-丁酮的方法:a. The method for preparing (S)-1-(2-furyl)-4-nitro-3-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU :

将15mg(0.1mmol)底物硝基苯乙烯,6.6mg(0.015mmol)脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU,1.8mg(0.015mmol)苯甲酸溶于0.8ml二氯甲烷中,在0℃条件下加入34mg(0.3mmol)呋喃酮,反应2小时后,在室温下继续反应72小时。反应完全后,用二氯甲烷萃取三次(每次8ml),用2g无水硫酸钠干躁。浓缩、柱层析(H60硅胶,石油醚∶乙酸乙酯=8∶1)得到(S)-1-(2-呋喃基)-4-硝基-3-苯基-1-丁酮20.0mg(85%产率)。Dissolve 15mg (0.1mmol) substrate nitrostyrene, 6.6mg (0.015mmol) dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, 1.8mg (0.015mmol) benzoic acid in 0.8ml di In methyl chloride, 34 mg (0.3 mmol) of furanone was added at 0° C., and after 2 hours of reaction, the reaction was continued at room temperature for 72 hours. After the reaction was complete, it was extracted three times with dichloromethane (8ml each time), and dried with 2g of anhydrous sodium sulfate. Concentration and column chromatography (H60 silica gel, petroleum ether: ethyl acetate = 8:1) gave (S)-1-(2-furyl)-4-nitro-3-phenyl-1-butanone 20.0mg (85% yield).

[α]20 D=-6(c=1.5,CHCl3)。[α] 20 D = -6 (c = 1.5, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收268nm.)tmajor=12.38min,tminor=15.92min,对映体选择性达到98%;High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 268nm.) t major = 12.38min, t minor = 15.92min, Enantioselectivity reaches 98%;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-1-(2-呋喃基)-4-硝基-3-苯基-1-丁酮的方法:b. The method for preparing (R)-1-(2-furyl)-4-nitro-3-phenyl-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU :

将15mg(0.1mmol)底物硝基苯乙烯,6.6mg(0.015mmol)脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU,1.8mg(0.015mmol)苯甲酸溶于0.8ml二氯甲烷中,在0℃条件下加入34mg(0.3mmol)呋喃酮,反应2小时后,在室温下继续反应72小时。反应完全后,用二氯甲烷萃取三次(每次8ml),用2g无水硫酸钠干躁。浓缩、柱层析(H60硅胶,石油醚∶乙酸乙酯=8∶1)得到(R)-1-(2-呋喃基)-4-硝基-3-苯基-1-丁酮21.0mg(82%产率)。[α]20 D=+4(c=1.5,CHCl3)。Dissolve 15mg (0.1mmol) substrate nitrostyrene, 6.6mg (0.015mmol) dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, 1.8mg (0.015mmol) benzoic acid in 0.8ml di In methyl chloride, 34 mg (0.3 mmol) of furanone was added at 0° C., and after 2 hours of reaction, the reaction was continued at room temperature for 72 hours. After the reaction was complete, it was extracted three times with dichloromethane (8ml each time), and dried with 2g of anhydrous sodium sulfate. Concentration and column chromatography (H60 silica gel, petroleum ether: ethyl acetate = 8:1) gave (R)-1-(2-furyl)-4-nitro-3-phenyl-1-butanone 21.0 mg (82% yield). [α] 20 D = +4 (c = 1.5, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收268nm.)tmajor=15.81min,tminor=12.35min,对映体选择性达到98%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 268nm.) t major = 15.81min, t minor = 12.35min, Enantioselectivity reaches 98%.

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.56(s,1H),7.24-7.31(m,5H),7.16(m,1H),7.35(s,1H),4.76-4.81(dd,J=6.8Hz,12.4Hz,1H),4.64-4.69(m,1H),4.15-4.18(m,1H),3.22-3.37(m,2H);13C NMR(100MHz,CDCl3):δ185.9,152.4,146.6,138.8,129.1,127.9,127.4,117.5,112.5,79.5,41.2,39.1. 1 H NMR (400MHz, CDCl 3 ): δ7.56(s, 1H), 7.24-7.31(m, 5H), 7.16(m, 1H), 7.35(s, 1H), 4.76-4.81(dd, J= 6.8Hz, 12.4Hz, 1H), 4.64-4.69(m, 1H), 4.15-4.18(m, 1H), 3.22-3.37(m, 2H); 13 C NMR (100MHz, CDCl 3 ): δ185.9, 152.4, 146.6, 138.8, 129.1, 127.9, 127.4, 117.5, 112.5, 79.5, 41.2, 39.1.

红外光谱分析:3588,3352,3126,2921,2852,1959,1655,1544,1464,1430,1381,1238,1162,1091,1032,919,762,702,548cm-1.Infrared spectral analysis: 3588, 3352, 3126, 2921, 2852, 1959, 1655, 1544, 1464, 1430, 1381, 1238, 1162, 1091, 1032, 919, 762, 702, 548cm -1 .

高分辨质谱分析:High-resolution mass spectrometry analysis:

HRMS-ESI(m/z):calcd for C14H13NO4+NH4 +:277.1183;found:277.1186,1.1ppm.HRMS-ESI(m/z): calcd for C 14 H 13 NO 4 +NH 4 + : 277.1183; found: 277.1186, 1.1ppm.

实施例17:(S)-3-(2-氯苯基)-1-(2-呋喃基)-4-硝基-1-丁酮和(R)-3-(2-氯苯基)-1-(2-呋喃基)-4-硝基-1-丁酮结构式如下:Example 17: (S)-3-(2-chlorophenyl)-1-(2-furyl)-4-nitro-1-butanone and (R)-3-(2-chlorophenyl) -1-(2-furyl)-4-nitro-1-butanone structural formula is as follows:

Figure C20081015014000251
Figure C20081015014000251

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-3-(2-氯苯基)-1-(2-呋喃基)-4-硝基-1-丁酮,制备过程中用硝基邻氯苯乙烯18.4mg(0.1mmol)替代了实施例16中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例16相同。(S)-3-(2-氯苯基)-1-(2-呋喃基)-4-硝基-1-丁酮得到81%产率。a. Preparation of (S)-3-(2-chlorophenyl)-1-(2-furyl)-4-nitro-1 with dehydroabietamine-thiourea catalyst (1R,2R)-CHDA-DHATU - butanone, 18.4 mg (0.1 mmol) of nitro-o-chlorostyrene was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 16 during the preparation process, and the preparation process was the same as in Example 16. (S)-3-(2-Chlorophenyl)-1-(2-furyl)-4-nitro-1-butanone was obtained in 81% yield.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收265nm.)tmajor=12.45min,tminor=13.74min,对映体选择性大于99%;High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 265nm.) t major = 12.45min, t minor = 13.74min, Enantioselectivity greater than 99%;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-3-(2-氯苯基)-1-(2-呋喃基)-4-硝基-1-丁酮,制备过程中用硝基邻氯苯乙烯18.4mg(0.1mmol)替代了实施例16中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例16相同。(R)-3-(2-氯苯基)-1-(2-呋喃基)-4-硝基-1-丁酮得到82%产率。b. Preparation of (R)-3-(2-chlorophenyl)-1-(2-furyl)-4-nitro-1 with dehydroabietamine-thiourea catalyst (1S,2S)-CHDA-DHATU - butanone, 18.4 mg (0.1 mmol) of nitro-o-chlorostyrene was used to replace 15 mg (0.1 mmol) of nitrostyrene in Example 16 during the preparation process, and the preparation process was the same as in Example 16. (R)-3-(2-Chlorophenyl)-1-(2-furyl)-4-nitro-1-butanone was obtained in 82% yield.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收265nm.)tmajor=13.12min,tminor=11.91min,对映体选择性大于99%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 265nm.) t major = 13.12min, t minor = 11.91min, Enantioselectivity greater than 99%.

核磁分析:NMR analysis:

1H NMR(300MHz,CDCl3):δ7.59(s,1H),7.39-7.42(m,1H),7.22-7.26(m,4H),6.54-6.55(dd,J=1.5Hz,3.6Hz,1H),4.85-4.88(d,J=6.9Hz,2H),4.62-4.67(m,1H),3.40-3.43(dd,J=1.8Hz,7.2Hz,2H);13C NMR(75MHz,CDCl3):δ185.8,146.7,135.9,133.8,130.4,129.1,128.4,127.4,117.6,112.5,39.6,35.9. 1 H NMR (300MHz, CDCl 3 ): δ7.59(s, 1H), 7.39-7.42(m, 1H), 7.22-7.26(m, 4H), 6.54-6.55(dd, J=1.5Hz, 3.6Hz , 1H), 4.85-4.88(d, J=6.9Hz, 2H), 4.62-4.67(m, 1H), 3.40-3.43(dd, J=1.8Hz, 7.2Hz, 2H); 13 C NMR (75MHz, CDCl 3 ): δ185.8, 146.7, 135.9, 133.8, 130.4, 129.1, 128.4, 127.4, 117.6, 112.5, 39.6, 35.9.

高分辨质谱分析:High-resolution mass spectrometry analysis:

HRMS-ESI(m/z):calcd for C14H12ClNO4+NH4 +:311.0793;found:311.0789,1.3ppm.HRMS-ESI(m/z): calcd for C 14 H 12 ClNO 4 +NH 4 + : 311.0793; found: 311.0789, 1.3ppm.

实施例18:(S)-1,3-二(2-呋喃基)-4-硝基-1-丁酮和(R)-1,3-二(2-呋喃基)-4-硝基-1-丁酮结构式如下:Example 18: (S)-1,3-bis(2-furyl)-4-nitro-1-butanone and (R)-1,3-bis(2-furyl)-4-nitro The structural formula of -1-butanone is as follows:

Figure C20081015014000261
Figure C20081015014000261

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-1,3-二(2-呋喃基)-4-硝基-1-丁酮,制备过程中用硝基-2-呋喃乙烯14mg(0.1mmol)替代了实施例16中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例16相同。a. Prepare (S)-1,3-bis(2-furyl)-4-nitro-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, during the preparation process The 15 mg (0.1 mmol) of nitrostyrene in Example 16 was replaced with 14 mg (0.1 mmol) of nitro-2-furan vinyl, and the preparation process was the same as in Example 16.

(S)-1,3-二(2-呋喃基)-4-硝基-1-丁酮得到83%产率。(S)-1,3-Bis(2-furyl)-4-nitro-1-butanone was obtained in 83% yield.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收245nm.)tmajor=20.75min,tminor=22.09min,对映体选择性大于99%;High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 245nm.) t major = 20.75min, t minor = 22.09min, Enantioselectivity greater than 99%;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-1,3-二(2-呋喃基)-4-硝基-1-丁酮,制备过程中用硝基-2-呋喃乙烯14mg(0.1mmol)替代了实施例16中的15mg(0.1mmol)硝基苯乙烯,其制备过程与实施例16相同。b. Prepare (R)-1,3-bis(2-furyl)-4-nitro-1-butanone with dehydroabietamine-thiourea catalyst (1S,2S)-CHDA-DHATU, during the preparation process The 15 mg (0.1 mmol) of nitrostyrene in Example 16 was replaced with 14 mg (0.1 mmol) of nitro-2-furan vinyl, and the preparation process was the same as in Example 16.

(R)-1,3-二(2-呋喃基)-4-硝基-1-丁酮得到81%产率。(R)-1,3-Bis(2-furyl)-4-nitro-1-butanone was obtained in 81% yield.

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收245nm.)tmajor=22.11min,tminor=20.89min,对映体选择性达到98%。High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 245nm.) t major = 22.11min, t minor = 20.89min, Enantioselectivity reaches 98%.

核磁分析:NMR analysis:

1H NMR(300MHz,CDCl3):δ7.60(s,1H),7.34(s,1H),7.22-7.26(m,1H),6.56-6.57(m,1H),6.19-6.30(m,2H),4.71-4.83(m,2H),4.25-4.34(m,1H),3.24-3.44(m,2H);13C NMR(75MHz,CDCl3):δ185.5,152.2,151.6,146.8,142.3,117.7,112.5,110.5,107.3,77.1,38.7,33.0. 1 H NMR (300MHz, CDCl 3 ): δ7.60(s, 1H), 7.34(s, 1H), 7.22-7.26(m, 1H), 6.56-6.57(m, 1H), 6.19-6.30(m, 2H), 4.71-4.83 (m, 2H), 4.25-4.34 (m, 1H), 3.24-3.44 (m, 2H); 13 C NMR (75MHz, CDCl 3 ): δ185.5, 152.2, 151.6, 146.8, 142.3, 117.7, 112.5, 110.5, 107.3, 77.1, 38.7, 33.0.

高分辨质谱分析:High-resolution mass spectrometry analysis:

HRMS-ESI(m/z):calcd for C12H11NO5+NH4 +:267.0975;found:267.0982,2.6ppm.HRMS-ESI(m/z): calcd for C 12 H 11 NO 5 +NH 4 + : 267.0975; found: 267.0982, 2.6ppm.

实施例19:(S)-4-硝基-3-苯基-1-(2-噻吩基)-1-丁酮和(R)-4-硝基-3-苯基-1-(2-噻吩基)-1-丁酮结构式如下:Example 19: (S)-4-nitro-3-phenyl-1-(2-thienyl)-1-butanone and (R)-4-nitro-3-phenyl-1-(2 -Thienyl)-1-butanone structural formula is as follows:

Figure C20081015014000271
Figure C20081015014000271

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-4-硝基-3-苯基-1-(2-噻吩基)-1-丁酮,制备过程中用2-噻吩酮37.8mg(0.3mmol)替代了实施例16中的34mg(0.3mmol)呋喃酮,其制备过程与实施例16相同。(S)-4-硝基-3-苯基-1-(2-噻吩基)-1-丁酮得到68%产率。a. Prepare (S)-4-nitro-3-phenyl-1-(2-thienyl)-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, prepare In the process, 37.8 mg (0.3 mmol) of 2-thienone was used to replace 34 mg (0.3 mmol) of furanone in Example 16, and the preparation process was the same as that of Example 16. (S)-4-Nitro-3-phenyl-1-(2-thienyl)-1-butanone was obtained in 68% yield.

[α]20 D=-62(c=1.0,CHCl3)。[α] 20 D = -62 (c = 1.0, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收261nm.)tmajor=13.07min,tminor=17.72min,对映体选择性达到98%;High performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane = 15/85, 1.0mL/min, UV absorption 261nm.) t major = 13.07min, t minor = 17.72min, Enantioselectivity reaches 98%;

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-4-硝基-3-苯基-1-(2-噻吩基)-1-丁酮,制备过程中用2-噻吩酮37.8mg(0.3mmol)替代了实施例16中的34mg(0.3mmol)呋喃酮,其制备过程与实施例16相同。(R)-4-硝基-3-苯基-1-(2-噻吩基)-1-丁酮得到66%产率。b. Prepare (R)-4-nitro-3-phenyl-1-(2-thienyl)-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU, prepare In the process, 37.8 mg (0.3 mmol) of 2-thienone was used to replace 34 mg (0.3 mmol) of furanone in Example 16, and the preparation process was the same as that of Example 16. (R)-4-Nitro-3-phenyl-1-(2-thienyl)-1-butanone was obtained in 66% yield.

[α]20 D=+48(c=1.4,CHCl3)。[α] 20 D = +48 (c = 1.4, CHCl 3 ).

高效液相分析(HPLC):(手性柱Chiralcel AD-H,异丙醇/正己烷=15/85,1.0mL/min,紫外吸收261nm.)tmajor=17.74min,对映体选择性大于99%。High-performance liquid phase analysis (HPLC): (chiral column Chiralcel AD-H, isopropanol/n-hexane=15/85, 1.0mL/min, UV absorption 261nm.) t major =17.74min, enantioselectivity greater than 99%.

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.67-7.68(dd,J=1.2Hz,4.0Hz,1H),7.63-7.64(dd,J=1.2Hz,4.0Hz,1H),7.23-7.34(m,5H),7.09-7.12(dd,J=4Hz,5.2Hz,1H),4.79-4.85(dd,J=6.4Hz,12.4Hz,1H),4.66-4.71(dd,J=8.0Hz,12.4Hz,1H),4.16-4.20(m,1H),3.30-3.42(m,2H);13C NMR(100MHz,CDCl3):δ189.7,143.6,138.8,134.3,132.2,129.1,128.2,127.96,127.4,79.4,42.1,39.5. 1 H NMR (400MHz, CDCl 3 ): δ7.67-7.68 (dd, J=1.2Hz, 4.0Hz, 1H), 7.63-7.64 (dd, J=1.2Hz, 4.0Hz, 1H), 7.23-7.34( m, 5H), 7.09-7.12 (dd, J = 4Hz, 5.2Hz, 1H), 4.79-4.85 (dd, J = 6.4Hz, 12.4Hz, 1H), 4.66-4.71 (dd, J = 8.0Hz, 12.4 Hz, 1H), 4.16-4.20 (m, 1H), 3.30-3.42 (m, 2H); 13 C NMR (100MHz, CDCl 3 ): δ189.7, 143.6, 138.8, 134.3, 132.2, 129.1, 128.2, 127.96 , 127.4, 79.4, 42.1, 39.5.

红外光谱分析:3390,3089,2921,2852,2509,1954,1658,1549,1413,1377,1270,1235,1057,942,855,726,699cm-1.Infrared spectral analysis: 3390, 3089, 2921, 2852, 2509, 1954, 1658, 1549, 1413, 1377, 1270, 1235, 1057, 942, 855, 726, 699cm -1 .

高分辨质谱分析:High-resolution mass spectrometry analysis:

HRMS-ESI(m/z):calcd for C14H13NO3S+NH4 +:293.0954;found:293.0961,2.4ppm.HRMS-ESI(m/z): calcd for C 14 H 13 NO 3 S+NH 4 + : 293.0954; found: 293.0961, 2.4ppm.

实施例20:(S)-4-硝基-3-苯基-1-(2-噻唑基)-1-丁酮和(R)-4-硝基-3-苯基-1-(2-噻唑基)-1-丁酮结构式如下:Example 20: (S)-4-nitro-3-phenyl-1-(2-thiazolyl)-1-butanone and (R)-4-nitro-3-phenyl-1-(2 -Thiazolyl)-1-butanone structural formula is as follows:

a.用脱氢松香胺-硫脲催化剂(1R,2R)-CHDA-DHATU制备(S)-4-硝基-3-苯基-1-(2-噻唑基)-1-丁酮,制备过程中用2-噻唑酮38mg(0.3mmol)替代了实施例16中的34mg(0.3mmol)呋喃酮,其制备过程与实施例16相同。(S)-4-硝基-3-苯基-1-(2-噻唑基)-1-丁酮得到80%产率。a. Prepare (S)-4-nitro-3-phenyl-1-(2-thiazolyl)-1-butanone with dehydroabietamine-thiourea catalyst (1R, 2R)-CHDA-DHATU, prepare In the process, 38 mg (0.3 mmol) of 2-thiazolone was used to replace 34 mg (0.3 mmol) of furanone in Example 16, and the preparation process was the same as that of Example 16. (S)-4-Nitro-3-phenyl-1-(2-thiazolyl)-1-butanone was obtained in 80% yield.

[α]20 D=-18(c=3.0,CHCl3);[α] 20 D = -18 (c = 3.0, CHCl 3 );

b.用脱氢松香胺-硫脲催化剂(1S,2S)-CHDA-DHATU制备(R)-4-硝基-3-苯基-1-(2-噻唑基)-1-丁酮,制备过程中用2-噻唑酮38mg(0.3mmol)替代了实施例16中的34mg(0.3mmol)呋喃酮,其制备过程与实施例16相同。(R)-4-硝基-3-苯基-1-(2-噻唑基)-1-丁酮得到80%产率。b. Prepare (R)-4-nitro-3-phenyl-1-(2-thiazolyl)-1-butanone with dehydroabietamine-thiourea catalyst (1S, 2S)-CHDA-DHATU, prepare In the process, 38 mg (0.3 mmol) of 2-thiazolone was used to replace 34 mg (0.3 mmol) of furanone in Example 16, and the preparation process was the same as that of Example 16. (R)-4-Nitro-3-phenyl-1-(2-thiazolyl)-1-butanone was obtained in 80% yield.

[α]20 D=+12(c=1.6,CHCl3)。[α] 20 D = +12 (c = 1.6, CHCl 3 ).

核磁分析:NMR analysis:

1H NMR(400MHz,CDCl3):δ7.97-7.98(d,J=3.2Hz,1H),7.66-7.67(d,J=2.8Hz,1H),7.22-7.33(m,5H),4.74-4.79(dd,J=7.2Hz,12.4Hz,1H),4.65-4.70(dd,J=8.0Hz,12.4Hz,1H),4.22-4.25(m,1H),3.72-3.78(dd,J=7.2Hz,17.6Hz,1H),3.53-3.59(dd,J=7.6Hz,18.0Hz,1H);13C NMR(100MHz,CDCl3):δ190.6,166.2,144.8,138.5,129.0,127.9,127.5,126.8,79.6,41.4,39.1. 1 H NMR (400MHz, CDCl 3 ): δ7.97-7.98 (d, J=3.2Hz, 1H), 7.66-7.67 (d, J=2.8Hz, 1H), 7.22-7.33 (m, 5H), 4.74 -4.79(dd, J=7.2Hz, 12.4Hz, 1H), 4.65-4.70(dd, J=8.0Hz, 12.4Hz, 1H), 4.22-4.25(m, 1H), 3.72-3.78(dd, J= 7.2Hz, 17.6Hz, 1H), 3.53-3.59 (dd, J=7.6Hz, 18.0Hz, 1H); 13 C NMR (100MHz, CDCl 3 ): δ190.6, 166.2, 144.8, 138.5, 129.0, 127.9, 127.5, 126.8, 79.6, 41.4, 39.1.

红外光谱分析:3418,2928,2254,2128,1652,1550,1449,1379,1026,1001,826,765,629cm-1.Infrared spectrum analysis: 3418, 2928, 2254, 2128, 1652, 1550, 1449, 1379, 1026, 1001, 826, 765, 629cm -1 .

高分辨质谱分析:High-resolution mass spectrometry analysis:

HRMS-ESI(m/z):calcd for C13H12N2O3S[M+H]+:277.0641;found:277.0643,0.7ppm.HRMS-ESI (m/z): calcd for C 13 H 12 N 2 O 3 S[M+H] + : 277.0641; found: 277.0643, 0.7ppm.

附图说明 Description of drawings

图1为硫脲催化剂1a,2a-2b,3a,4a-4b,5a和6a-6b的化学结构式示意图。Figure 1 is a schematic diagram of the chemical structural formulas of thiourea catalysts 1a, 2a-2b, 3a, 4a-4b, 5a and 6a-6b.

图2为糖环衍生硫脲催化剂6a-6b在合成(S)-或(R)-γ-硝基酮中催化活性对比示意图。Fig. 2 is a schematic diagram of comparative catalytic activity of sugar ring-derived thiourea catalysts 6a-6b in the synthesis of (S)- or (R)-γ-nitroketone.

Claims (3)

1. class dehydroabietylamine-chirality thiourea catalyst, its structural formula is as follows:
Figure C2008101501400002C1
2. use the method for synthetic (S)-γ-nitro of dehydroabietylamine-chirality thiourea catalyst high antimer both hands control-fragrant ketone in the claim 1 or (R)-γ-nitro-fragrant ketone chiral compound, it is characterized in that with substrate nitroolefin compound and consumption be dehydroabietylamine-chirality thiourea catalyst of substrate nitroolefin compound 15mol%, consumption is that substrate nitroolefin compound 15mol% benzoic acid is dissolved in the carrene, adding consumption under 0 ℃ of condition is 3 times of amounts of substrate nitroolefin compound aromatic ketone compound, react after 2 hours, at room temperature continue reaction 60 hours, after reacting completely, column chromatography obtains end-product, wherein (S)-γ-nitro-fragrant ketone or (R)-γ-nitro-fragrant ketone chiral compound, the nitroolefin compound, the structural formula of aromatic ketone compound is as follows: a is an aromatic ketone; B is a nitroolefin; C is (S)-γ-nitro-fragrant ketone; D is (R)-γ-nitro-fragrant ketone:
Figure C2008101501400002C2
Wherein, R 1For-H, or be-Me, or be-OMe, or be-Cl, or be-Br, or be-F,
R 2For-Ph, or be-naphthyl, or be-Cl-Ph, or be-Br-Ph, or be-F-Ph, or be-thienyl, or be-furyl, or be-Me-Ph, or be-OMe-Ph.
3. use the mix method of ketone chiral compound of synthetic (S)-γ-nitro of dehydroabietylamine-chirality thiourea catalyst high antimer both hands control in the claim 1-assorted ketone of fragrance or (R)-γ-nitro-fragrance, it is characterized in that with substrate nitroolefin compound and consumption be dehydroabietylamine-chirality thiourea catalyst of substrate nitroolefin compound 15mol%, consumption is that substrate nitroolefin compound 15mol% benzoic acid is dissolved in the carrene, adding consumption under 0 ℃ of condition is 3 times of assorted ketonic compounds of amount fragrance of substrate nitroolefin compound, react after 2 hours, at room temperature continue reaction 72 hours, after reacting completely, column chromatography obtains end-product, wherein the assorted ketone of (S)-γ-nitro-fragrance or (R)-γ-nitro-fragrance ketone chiral compound of mixing, the nitroolefin compound, the structural formula of the assorted ketonic compound of fragrance is as follows: a is a nitroolefin; B is the assorted ketone of fragrance; C is the assorted ketone of (S)-γ-nitro-fragrance; D is the assorted ketone of (R)-γ-nitro-fragrance:
Figure C2008101501400003C1
Wherein, X is O, or is S; Y is C, or is N,
R 3For-Ph, or be-naphthyl, or be-Cl-Ph, or be-Br-Ph, or be-F-Ph, or be-thienyl, or be-furyl, or be-Me-Ph, or be-OMe-Ph,
R 4For-H, or be-Me, or be-Cl, or be-Br, or be-F,
R 5For-H, or be-Me, or be-Cl, or be-Br, or be-F,
R 6For-H, or be-Me, or be-Cl, or be-Br, or be-F,
R 7For-H, or be-Me, or be-Cl, or be-Br, or be-F,
R 8For-H, or be-Me.
CN200810150140A 2008-06-21 2008-06-21 Application of Dehydroabietine Aminothiourea Catalyst in High Enantiomeric Two-handed Synthesis of Chiral Compounds Expired - Fee Related CN100584459C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200810150140A CN100584459C (en) 2008-06-21 2008-06-21 Application of Dehydroabietine Aminothiourea Catalyst in High Enantiomeric Two-handed Synthesis of Chiral Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN200810150140A CN100584459C (en) 2008-06-21 2008-06-21 Application of Dehydroabietine Aminothiourea Catalyst in High Enantiomeric Two-handed Synthesis of Chiral Compounds

Publications (2)

Publication Number Publication Date
CN101318146A CN101318146A (en) 2008-12-10
CN100584459C true CN100584459C (en) 2010-01-27

Family

ID=40178564

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200810150140A Expired - Fee Related CN100584459C (en) 2008-06-21 2008-06-21 Application of Dehydroabietine Aminothiourea Catalyst in High Enantiomeric Two-handed Synthesis of Chiral Compounds

Country Status (1)

Country Link
CN (1) CN100584459C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101982460B (en) * 2010-09-16 2013-05-15 广西师范大学 Dehydroabietyl thiourea derivative and its preparation method and application
CN102120740B (en) * 2010-11-17 2013-04-17 兰州大学 Imidazoline compound chirally synthesized by using thiourea catalyst derived from rosin and application thereof in anti-inflammatory and antipyretic aspects
CN103421044A (en) * 2012-05-17 2013-12-04 华东理工大学 Chiral phosphine thiourea compound containing dehydroabietylamine structure unit, preparation method and applications thereof
CN111423430B (en) * 2019-01-10 2023-10-13 中山大学 Fluorescent probes and preparation methods thereof
CN113773475B (en) * 2021-10-14 2022-06-07 安徽大学 Catalyst containing bithiophene structure and application thereof in ring-opening polymerization of cyclic ester under light control

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
A chiral primary amine thiourea catalyst for the highlyenantioselective direct conjugate addition of α,α-disubstituted aldehydes to nitroalkenes. Mathieu P.Lalonde,et al.Angew.chem.int.ed,Vol.45. 2006 *

Also Published As

Publication number Publication date
CN101318146A (en) 2008-12-10

Similar Documents

Publication Publication Date Title
Yang et al. Multifunctional chiral phosphines-catalyzed highly diastereoselective and enantioselective substitution of Morita–Baylis–Hillman adducts with oxazolones
EP2570416B1 (en) Antiviral bisfuran derivative as hiv protease inhibitor and intermediates thereof
CN100584459C (en) Application of Dehydroabietine Aminothiourea Catalyst in High Enantiomeric Two-handed Synthesis of Chiral Compounds
Fang et al. Asymmetric cyclizations via a sequential Michael addition/Conia-ene reaction by combining multifunctional quaternary phosphonium salt and silver catalysis
NZ250577A (en) Biphenyl intermediates and preparation thereof
CN110054553A (en) The method that organic boronic reacts synthesizing optical activity ketone compounds with the asymmetric conjugated reaction of alpha, beta-unsaturated ketone
CN103788056B (en) Chirality 1-replaces-1-ethylene glycol, intermediate and preparation method thereof
Malkov et al. Amino acid-derived hydroxamic acids as chiral ligands in the vanadium catalysed epoxidation
Mao et al. Synthesis of 1-deoxymannojirimycin analogues using N-tosyl and N-nosyl activated aziridines derived from 1-amino-1-deoxyglucitol
CN112154140A (en) Compound and application thereof in synthesizing bulk drug of Brivaracetam (Brivaracetam)
WO2016039691A1 (en) Catalysts for making chiral heterocyclic sulfoxides
Li et al. An efficient enantioselective synthesis of florfenicol via a vanadium-catalyzed asymmetric epoxidation
CN104557583A (en) Method for synthesizing gamma-aminobutyric acid chiral compound
CN107400105A (en) Method for efficiently synthesizing optically active polysubstituted 2, 3-dihydrofuran compound by asymmetric organic catalysis
CN102351769A (en) Chiral 2,5-pyrroline derivative, and synthetic method and biological activity thereof
CN106588811B (en) A kind of method of sulfamide compound in benzo of the asymmetric syntheses containing chiral quaternary carbon center
JP6006634B2 (en) Method for producing epinastine using isourea compound
CN111808041B (en) Difluoroalkyl aryl oxazolidinone compound and preparation method thereof
CN114369053A (en) Sulfonylated pyrrolidone series compounds and preparation method thereof
CN101835745B (en) Preparation method of disulfonic acid compound, asymmetric Mannich catalyst, preparation method of β-aminocarbonyl derivative and disulfonate
CN108658934B (en) Preparation method of 1, 2-disulfide-3-thioketone derivative synthesized by copper catalysis
CN112500419A (en) Epoxy fused 2-methylene pyrrolidine compound and preparation method thereof
CN116514834A (en) Chiral alpha-CF 2 H spiro [ pyrrolidine-pyrazolones]Synthesis method of class compound
KR101446017B1 (en) Method for the stereoselective preparation of 4-alkyl-5-aryl 5-membered ring sulfamidates
CN109020860A (en) A kind of 2- aryl -3- ester group polysubstituted pyrrole class compound and its method for synthesizing and refining

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100127

Termination date: 20140621

EXPY Termination of patent right or utility model